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ABSTRACT
Vera Biryukova
EFFECTIVENESS OF A TREATMENT APPROACH FOR COMORBID PANIC
DISORDER, MAJOR DEPRESSIVE DISORDER, AND ALCOHOL
DEPENDENCE: A CASE STUDY
2004/2004
Dr. James A. Haugh
Master of Arts in Mental Health Counseling
This case study evaluates the effectiveness of cognitive-behavioral
therapy with a focus on therapeutic relationship in the treatment of an adult
female who underwent treatment in a community mental health agency. The
client was diagnosed with comorbid panic disorder, major depressive disorder,
and alcohol dependence. In addition, the client experienced a variety of
psychosocial stressors. The client's psychosocial assessment is presented, and
the empirical treatment literature related to the client's diagnoses is reviewed. A
variety of outcome measures were used. Results indicated that the treatment
was effective: the client experienced a significant reduction in the severity of
symptoms. However, further treatment is needed to extend the improvement in
symptoms and to reduce the risk of future relapse. A comparison between the
client's current treatment and what might be considered "best" treatment is
presented. Suggestions for treatment improvement are made.
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Name: Ms. Gloria Williams'
Date of Birth: 1962
Treatment Dates: March - June 2003 (14 Sessions)
Treatment Provider: Vera Biryukova, Mental Health Counseling Graduate Student
Presenting Problem
Ms. Williams is a 41-year old Caucasian female who was referred to this agency from
a social service agency for people experiencing mental illness. She presented to treatment
following a separation from her fianc6 who she had been dating for four years. She reported
that her fianc6 did not want to put up with her alcohol abuse anymore and broke up with her.
According to Ms. Williams, her fianc6 bought her an airplane ticket to New Jersey in
November of 2002 after telling her that the relationship was over. Ms. Williams reported that
she has experienced severe depressive symptoms, high levels of anxiety, and frequent panic
attacks following the break-up. In addition, she reported that she started to drink more
frequently after the break up.
With regard to her anxiety symptoms, Ms. Williams stated that she was feeling
shaky, agitated, and "edgy". In addition, Ms. Williams reported having seven panic attacks a
day, on average, during which she reported experiencing heart palpitations, breathing
difficulties, chest pain, dizziness, sweating, shaking, and a fear that she was going crazy.
Finally, Ms. Williams reported fear of having subsequent panic attacks, which had resulted in
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the development of agoraphobic behavior such as avoiding driving on highways and being
outside of her home alone.
With respect to depressive symptoms, Ms. Williams described feelings of sadness
and hopelessness, difficulty concentrating, loss of pleasure in activities she previously
enjoyed, feelings of guilt, loss of energy, and sleep/appetite disturbance. In addition, she
reported that in the month preceding her referral for treatment, she had difficulty getting out
of bed and did not shower or change clothes for 4-5 days in a row.
The final presenting problem reported by Ms. Williams was difficulty controlling her
alcohol use. Specifically, Ms. Williams reported that during the past three months she
engaged in several drinking binges where she consumed 2-3 pints of vodka and 1-2 six-packs
of beer over the course of 2-4 days.
History of Presenting Problem
With regard to anxiety symptoms, Ms. Williams reported that she has been anxious as
long as she can remember. For example, she recalled that she was extremely shy and
withdrawn as a child and always felt insecure about her surroundings. In addition, she
reported being teased at school and feeling anxious when talking to people, answering
questions in class, and taking tests. While in high school, she reported that there were some
days that she "just could not go to school" because of the anxiety.
Ms. Williams reported that she was able to cope with her anxiety somewhat when she
started college and when she started her working career as a model. Specifically, she learned
to effectively cope with her test anxiety and social anxiety by "talking herself out" of anxious
thoughts so that they did not interfere with her job performance.
'Client's name and demographics have been changed to protect the client's confidentiality.
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In regard to her history of panic symptoms and attacks, Ms. Williams could not
remember the time and circumstances of the first panic attack she experienced. However, she
stated that most of her panic attacks were related to interpersonal stress she experienced in
the context of the "abusive" marriages she was in at that time. Ms. Williams stated that her
most frequent panic attacks occurred following the recent break-up with her fianc6, when the
number of attacks reached approximatelyl 5 a day. She was diagnosed with Panic Disorder in
19922 when she entered inpatient treatment for her alcohol dependence.
In addition to her anxiety and panic, Ms. Williams also reported a significant history
of experiencing depressive symptoms. Ms. Williams reported having one previous depressive
episode similar in severity to her current episode. She reported that this period of depression
occurred in 1992, when she was diagnosed with Major Depressive Disorder while
undergoing inpatient treatment for her alcohol dependence. Ms. Williams reported that this
depressive episode was triggered by her marriage, which she claims had become increasingly
physically abusive. Ms. Williams denied any current or past experience of Manic or
Hypomanic symptoms or episodes.
In regard to her drinking, Ms. Williams stated that she started drinking in her late
teens, when she would drink 1-2 times a month at parties with friends. She reported that ever
since she took the first drink at a party, she could not stop, wanted more and more, and
usually would drink to the point of intoxication. It was in her late teens that she realized that
drinking made her feel better by alleviating her anxiety. Ms. Williams was diagnosed with
alcohol dependence in 1992 and 1997, when she voluntarily sought treatment for her drinking
problem. Ms. Williams reported that her drinking increased to the point of dependence for the
first time in her late twenties, when she increasingly relied on alcohol to cope with the stress
2 Treatment dates are changed to protect the client's confidentiality
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associated with her abusive marriage. Ms. Williams reported that the other period of alcohol
dependence was related to her second marriage, which she reported as being very stressful,
although not abusive. Following treatment, Ms. Williams reported that she was able to
abstain from alcohol use for varying periods of time, with her longest period of abstinence
being 14 months.
In September 2001, his current employer transferred Ms. Williams' fianc6 to another
state. Ms. Williams joined him after two months, and reported that her alcohol use increased
because of many stressors she experienced as a result of this transition. After Ms. Williams'
fiance broke up with her, she reported that she started drinking even more, engaging in
drinking binges for several days.
Ms. Williams denied any current drug use, although she admitted to experimenting
with marijuana in high school. She said that her experimentation with marijuana was
unpleasant, and that she has refrained from drug use since then.
Treatment History and Other Agency Involvement
Ms. Williams was diagnosed with panic disorder, major depressive disorder and
alcohol dependence in 1992, when she entered treatment for her alcohol dependence. The
treatment included inpatient alcohol detoxification and rehabilitation and outpatient
counseling that addressed her drinking problem, anxiety, and depression. She was prescribed
Xanax for her anxiety. In addition, she joined Alcoholics Anonymous. In 1997, Ms. Williams
became alcohol dependent again and went through the same treatment. Ms. Williams
indicated that the treatments helped her to gain insight into the abusive nature of the
marriages she was in and how her relationship with her husbands influenced the development
of the depression and exacerbated her anxiety and alcohol problems. In addition, Ms.
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Williams reported that in therapy she learned some techniques, such as meditation and
biofeedback, which she used to alleviate her anxiety.
Ms. Williams reported that she was currently involved with a social service agency
for people with mental illness. She was assigned a caseworker who was helping her to apply
for welfare and disability compensation, and who had referred her to this agency for
additional mental health treatment.
Family Relationships
Ms. Williams reported growing up in a family consisting of her parents, her fraternal
twin brother, and herself. Her parents were married for over 30 years. However, Ms.
Williams' father passed away six years ago. Currently, her mother lives alone. Ms. Williams
stated that she still keeps contact with her mother. However, she reported that her relationship
with her mother is currently strained because of her continued drinking. Ms. Williams stated
that her brother lives in the area and that she keeps in contact with him as well, but that their
relationship is also strained due to her continued drinking.
Ms. Williams described her family as "disorganized" while she was growing up.
Specifically, she stated that her parents fought all the time. In addition, she reported that her
father was frequently physically abusive to her mother in front of the children. Moreover,
Ms. Williams recalled that their neighbors told her that she and her brother were often
neglected in their early childhood. Ms. Williams stated that her parents were very controlling
and emotionally abusive. For example, her mother would frequently say that she was stupid
and that she would never amount to anything.
In addition to these problems, Ms. Williams also reported that her mother's mood
was very hard to predict, that she abused alcohol, and that she was "obsessive -compulsive."
To exemplify her mother's "obsessive-compulsive" features, Ms. Williams described how
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her mother would not let the children do things like dressing themselves, cleaning, or
helping her in the kitchen for fear that they would mess something up.
Ms. Williams reported that neither herself nor her siblings were physically or
sexually abused during their childhood.
Relationship History
Ms. Williams reported being married twice. She first married at age 21 and has a 19-
year-old daughter by her first husband. She stated that her first husband had an "anger
problem" and that he was physically, sexually, and verbally abusive to her. Specifically, Ms.
Williams reported that her husband frequently beat her in front of their daughter, forced her
to have sex, called her names, and often told her that she was worthless and stupid. She
divorced him in 1991 after eight and a half years of marriage.
In 1994, Ms. Williams married her second husband after dating him for 3 years. Her
second husband at that time was allegedly recovering from alcohol dependence. Ms.
Williams described this marriage as emotionally uninvolved, and stated that her husband was
"totally indifferent" to her. According to Ms. Williams' report, he did not like to spend time
with her, repeatedly lied to her, was verbally abusive with her daughter, and abused
prescription drugs. Ms. Williams divorced him after two years of marriage.
Ms. Williams reported that she met her last boyfriend four years ago while still
married to her second husband. She described this relationship as "perfect" and mutually
rewarding. However, Ms. Williams reported that there was a brief period of separation
caused by her boyfriend's desire to sort out his feelings about the relationship. According to
Ms. Williams' report, this separation was precipitated by a surgery that her boyfriend
underwent due to prostate cancer and his ensuing depression. Ms. Williams described these
difficulties as minor and stated that her boyfriend was talking about the two of them getting
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married. However, she reported that he was transferred to Louisiana toward the end of 2001,
and that the plan was for her to stay in New Jersey to get experience with her new job while
he settled down in Louisiana. However, after two months, she reportedly decided to move to
Louisiana as well because she felt lonely and insecure and was afraid that her fiance would
leave her.
While in Louisiana, Ms. Williams reportedly experienced many stressors. These
included adjusting to the new place and difficulty finding a job. In addition, Ms. Williams
reported that her fiance worked about 80 hours a week and could not spend enough time with
her. Ms. Williams recalled that this lack of attention resulted in her increasing feelings of
loneliness, worthlessness, insecurity and depression, which lead to her increased alcohol use.
Ms. Williams stated that her fianc6 did not want to put up with her alcohol abuse any more
and broke up with her.
Ms. Williams currently resides with her cousin and her cousin's family, although she
sometimes stays with her mother as well. Ms. Williams' daughter currently lives with her
biological father. Ms. Williams described her current relationship with her mother as strained
and emotionally abusive. For example, her mother reportedly blames Ms. Williams for the
break-up with her fiance, and claims that Ms. Williams does not deserve to be married to "a
good man" because she is a "drunk".
Ms. Williams' relationship with her brother is also reportedly strained because of Ms.
Williams' alcohol dependency. For example, she stated that her brother and his wife kept her
car at their house because they did not trust her ability to refrain from driving while she was
under the influence of alcohol.
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Early Developmental and Neurological History
Ms. Williams was not aware of any complications during her mother's pregnancy and
delivery of her. In addition, she was not aware of any history of problems during her
developmental years. Ms. Williams reported no history of neurological problems or head
trauma.
Health History
When asked about her health, Ms. Williams reported several medical problems.
Specifically, she reported that she was legally blind, and that she had been diagnosed with
mitral valve prolapse and fibromialgia. Ms. Williams also reported a history of migraine
headaches about 1-2 times a year. Ms. Williams was not taking any medications or seeking
any treatment for these health problems at the time of this assessment.
With regard to psychiatric history, Ms. Williams reported that she was diagnosed
with Major Depressive Disorder, Panic Disorder and Alcohol Dependence in 1992 when she
sought treatment for her drinking problem. She reported a history of two voluntary
hospitalizations (in 1992 and 1997) for alcohol detoxification and rehabilitation.
Additionally, she was in outpatient counseling following both hospitalizations.
Regarding the family psychiatric history, Ms. Williams stated that her grandfather
was abusive and had an "anger problem". In addition, she reported that there is a history of
alcohol abuse in the family. Specifically, Ms. Williams stated that both her mother and
maternal grandmother abused alcohol. Finally, Ms. Williams described her mother as
"obsessive-compulsive". For example, Ms. Williams' mother reportedly did not allow her to
cook or clean in her house because she was afraid that Ms. Williams would mess things up.
However, her mother was never professionally diagnosed with OCD or any other psychiatric
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disorder. Ms. Williams was not aware of any history of psychiatric hospitalizations or
outpatient psychological treatment in her family of origin.
Educational and Work History
Ms. Williams reported having a total of 14 years of education. She described herself
as an average student throughout her education. She graduated from high school and
completed two years of college. Ms. Williams indicated that she wanted to be a model after
she graduated from high school, but that her parents were against this career choice. As a
result, Ms. Williams reported that she ended up pursuing a degree in commercial arts.
However, she reported that she started to get numerous offers to work as a photo model
during her first year of college. Ms. Williams reported that after some deliberation, she
finally decided to drop out of college and become a model. Ms. Williams spoke of her 20
years career in modeling as successful and satisfactory.
In addition to modeling, Ms. Williams reported always being interested in the field of
health care, especially surgery. She reported that this interest was re-ignited after her fiance
had surgery for cancer and she had the opportunity to take care of him after the surgery.
Reportedly, professional nurses expressed a very high opinion of the quality of care she
provided, which, along with prompting from her fiance, precipitated a change in her career.
In 2001, she went to school to get a surgeon technician's degree. She reported that she had
worked as a surgeon technician for about a year when her alcohol use started to interfere with
her job performance and she quit her job.
Ms. Williams is currently unemployed. She stated that she currently lives off money
she saved while she was still working. However, Ms. Williams indicated that her savings are
insufficient for living independently and that she has no other source of income at this time.
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To make the ends meet, Ms. Williams has applied for disability compensation and intends to
apply for welfare.
Social Support
Ms. Williams reported having one close friend - her cousin. She stated that her
cousin is a recovered alcoholic and that she is always emotionally supportive for Ms.
Williams. Moreover, she offered to let Ms. Williams to live in her house until she is able to
support herself financially. She is also Ms. Williams' only Alcoholics Anonymous (AA)
sponsor at the present.time. Ms. Williams stated that although she started to go to AA
meetings, she does so infrequently and she has not established a good Alcoholics Anonymous
support system yet.
Ms. Williams also cited her daughter as being a great support, but stated that they
only communicate by phone about once a week because her daughter is away at college,
living with her father.
Ms. Williams also reported that she could sometimes count on her mother for support
in terms of finances and a place to stay. However, she said that she usually avoided turning to
her mother for emotional support because her mother often drank heavily and her mood was
very unpredictable.
Situational Stressors
Ms. Williams reported the existence of a variety of stressors at the current time. She
spoke of the break -up with her fianc6 as the major event with which she has had a very hard
time coping. Specifically, she stated that she was very distressed about the fact that her ex-
fiance did not want to talk to her on the phone even to discuss practical matters such as
shipping her furniture and clothing from Louisiana. In terms of other interpersonal stressors,
Ms. Williams mentioned that her relationship with her mother was strained more than usual
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because of Ms. Williams' drinking. Also, she was very upset because her brother and his
wife treated her as if "she did not exist," as evidenced by making decisions about what she
should and should not do and not allowing her to use her car. Finally, Ms. Williams stated
that she greatly missed her daughter.
In addition to these stressors, Ms. Williams also reported a number of financial
difficulties. For example, she is unemployed, has no sources of additional income, and is
going to file for bankruptcy. At the same time, she has car payments due every month. In
addition, she does not have her own place to live, and she has to stay at her cousin's house or
with her mother when the mother is not drinking.
Coping Mechanisms and Strengths
Ms. Williams stated that she was very motivated for treatment, determined to work in
therapy, and was hopeful that the treatment would be beneficial. She had insight into her
problems demonstrated by her awareness of her psychiatric diagnoses and ability to actively
seek professional help. For example, she described how she found a social service agency in
the phone book, called the agency and asked for help with finding a community mental health
agency where she could receive therapy and medication. Ms. Williams appeared to be of at
least average verbal ability as evidenced by her ability to clearly communicate about different
topics, including, but not limited to, the concerns that brought her to treatment, when her
problems developed, and what she had done in the past to resolve her difficulties. She
appeared to be engaging and easygoing, as evidenced by her warm and pleasant manner of
speaking.
In terms of coping mechanisms, Ms. Williams stated that before the break-up with
her fiance, she would use walking, meditation and exercise to cope with the anxiety and
panic attacks. In addition, although she was not actively involved in church, religion helped
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her to get through some of her hard times. For example, Ms. Williams related that she often
read the bible and other spiritual literature to "get stronger". At the present time, however,
she reported that aside from turning to her cousin for support, she did not engage in any
healthy coping behaviors she used to utilize before the break-up with her fiance. Ms.
Williams stated that, presently, drinking and talking to her cousin are the only means by
which she coped with the emotional pain she was experiencing.
Review of Prior Assessments
No prior evaluations or assessments were available for review.
Summary and Conceptualization
Ms. Williams is a 41-year-old Caucasian female who presented to treatment
following a separation from her fiance. At the time of the assessment, Ms. Williams reported
high levels of anxiety and depression, and reported that she had been abusing alcohol. Ms.
Williams' problems with anxiety and alcohol abuse date back to her teenage years and she
reported one previous episode of major depressive disorder. Ms. Williams underwent two
voluntary hospitalizations for her alcohol problems, both of which were followed by
outpatient counseling that incorporated treatment of her anxiety and depression. Ms.
Williams has been married twice and has a 19-years old daughter. Ms. Williams is currently
unemployed, has no financial sources, and her social support is limited.
Ms. Williams's difficulties appear to have both biological and psychological roots. It
may be concluded from the information that Ms. Williams revealed about her family of
origin, that her mother appears to have untreated anxiety and alcohol use disorders, which
might have genetically predisposed Ms. Williams to anxiety and alcohol problems.
Additionally, she likely observed her mother using alcohol as a means of coping with anxiety
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and other stressors, thereby modeling such behavior and increasing the likelihood of their
use for the client.
Ms. Williams' account of her career as a model suggests that she was at least
somewhat able to successfully cope with her anxiety in work related situations. Moreover, for
the majority of her career, alcohol use did not appear to significantly negatively influence her
work performance. On the other hand, Ms. Williams appears to have some deficits in the area
of interpersonal relationships, as evidenced by the information she provided about her
relationships with significant others. Specifically, she reported being involved in two abusive
marriages and that the only rewarding relationship she has had resulted in a break-up.
The difficulties Ms. Williams experienced in the area of interpersonal relationships
might have been influenced by her childhood experiences. Specifically, controlling parenting
practices and alleged emotional abuse from her mother might have led to the development of
negative beliefs about herself as worthless and unlovable. Moreover, Ms. Williams' parents'
violent interactions with each other might have served as a dysfunctional model of a marital
relationship. It may be that the negative beliefs about herself and the violence she witnessed
in her parents' marriage served as a basis for Ms. Williams' own abusive marriages.
Similarly, the negative beliefs about herself, together with traumatic experiences of the
abusive marriage, appear to have influenced the development of Ms. Williams' first
depressive episode and panic disorder. At the same time, Ms. Williams' alcohol use might
have served simultaneously as a coping skill and as a factor exacerbating these disorders.
Although Ms. Williams was in treatment, apparently it focused on symptom relief
and only in part addressed the negative beliefs underlying her symptoms. This was evidenced
by the fact that she was finally able to stay away from abusive relationships and engage in a
satisfactory relationship. However, when life stresses seemed to threaten this relationship,
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and when it finally ended later, Ms. Williams' negative beliefs appear to have become
activated again. This led to another depressive episode, exacerbation of panic disorder and, in
the absence of adaptive coping skills and social support, to increased alcohol use.
Diagnostic Considerations and Differential Diagnosis
Based on the information gathered during the assessment, Ms. Williams appears to
have symptoms that satisfy criteria for Panic Disorder, Major Depressive Disorder, and
Alcohol Dependence.
The diagnosis of Panic Disorder, without Agoraphobia is given as the primary
diagnosis. This diagnosis is designated as primary due to the severity of the current
symptoms (e.g., approximately seven panic attacks a day) and because the client stated it as
being the primary source of distress and impairment. The primary anxiety symptoms reported
by Ms. Williams were recurrent, unexpected panic attacks, during which she reported
experiencing heart palpitations, breathing difficulties, chest pain, dizziness, sweating,
shaking, feelings of unreality, and fear that she was losing control and going crazy. In
addition, Ms. Williams reported a fear of having another panic attacks. Finally, her behavior
changed significantly, as evidenced by avoiding driving on highways and being outside of
home alone. All of these symptoms satisfy Criterion "A" for Panic Disorder.
To determine whether behavior changes related to panic attacks represent presence or
absence of agoraphobia (criterion "B"), the diagnostic criteria for Agoraphobia were also
considered. First, Criterion "A" for agoraphobia requires that a person experiences a fear of
being in places or situations from which escape might be difficult (or embarrassing) or in
which help may not be available in the event of having a panic attack. Ms. Williams reported
that her fear of driving on the highway was related to the heightened anxiety she experienced
14
when driving at high speeds, but she did not report specific fears of having a panic attack in
this situation. Thus, she does not meet the diagnostic criteria specified in Criterion "A."
Criterion "B" for agoraphobia requires that the situations from which escape may be
difficult or embarrassing are avoided or else endured with marked distress or anxiety. Ms.
Williams reported.that she feared to be alone outside of home. However, she reported that
this fear was related to a concern that if she were to go to places where she previously was
with her fiance, the memories of times spent together would trigger feelings of loss and grief.
Thus, Ms. Williams' avoidance of being outside of home alone was related to difficulty
coping with the end of the relationship rather than a fear of having a panic attack or a fear of
not getting help when having one.
The panic attacks experienced by Ms. Williams were not due to the direct
physiological effects of a substance or a general medical condition. Although sweating, hand
tremors, and anxiety may be symptoms of alcohol withdrawal, Ms. Williams reported that
she experienced panic attacks at times when she had not been using alcohol. Therefore, the
panic attacks cannot be accounted for direct effects of alcohol use (Criterion "C").
Because panic attacks may occur in other anxiety disorders, it was necessary to rule
them out (criterion "D"). Social phobia was ruled out because Ms. Williams' panic attacks
were not related to a fear of embarrassment in social situations. Similarly, they were not
related to specific phobic situations, as in Specific phobia, or to thoughts or exposure to the
object or situation related to an obsession as in Obsessive-Compulsive Disorder. Finally, Ms.
Williams' panic attacks were not related to worry as in Generalized Anxiety Disorder, or to
stimuli related to stressor as in Posttraumatic Stress Disorder.
Based on Ms. Williams' report of depressive symptoms she experienced, the second
diagnosis assigned was Major Depressive Disorder, Recurrent, Without Psychotic Features.
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Ms. Williams' symptom picture was consistent with her having currently been experiencing
a major depressive episode. Specifically, she had been experiencing symptoms for over 2-
weeks, and she was experiencing a number of symptoms consistent with the diagnostic
criteria. Specifically, she experienced depressed mood and loss of pleasure in previously
enjoyed activities, hopelessness, feelings of worthlessness and guilt, disturbances in sleep and
appetite, difficulty with concentration, and loss of energy. In addition, Ms. Williams'
symptoms satisfied Criterion "B" for a major depressive episode in that she denied the
presence of manic symptoms required to make a diagnosis of a Mixed episode. Criterion "C"
for a major depressive episode was satisfied because Ms. Williams' depressive symptoms
caused significant distress and impairment as evidenced by her report that she had difficulty
maintaining self-care. Criterion "D" was satisfied because Ms. Williams' symptoms were not
due to physiological effects of a substance or a medical condition, and Criterion "E" was
satisfied because the symptoms did not represent bereavement.
Ms. Williams did not report any psychotic symptoms, such as hallucinations and.
delusions; therefore, Criterion "B" for Major Depressive Disorder has been met. Similarly,
she reported no current or past history of Manic, Hypomanic, or Mixed episodes, which
satisfies Criterion "C" of the Major Depressive Disorder.
The specifier Recurrent was assigned because Ms. Williams reported a history of one
previous major depressive episode that occurred several years ago. The specifier Severe
Without Psychotic Features was given because Ms. Williams experienced most of the
symptoms required to make a diagnosis of Major Depressive Episode; she experienced severe
impairment in functioning, and she denied the presence of any psychotic symptoms.
Ms. Williams' current symptom picture was also consistent with the presence of
Alcohol Dependence, Without Physiological Dependence. To determine whether Ms.
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Williams' pattern of alcohol use represents presence of alcohol abuse or alcohol
dependence, the diagnostic criteria for substance abuse and substance dependence were
considered. Criterion "B" for Substance Abuse requires that the substance use symptoms
have never met the criteria for Substance Dependence for this class of substance. Ms.
Williams was diagnosed with Alcohol Dependence in the past; therefore, the diagnosis of
Alcohol Dependence was assigned. Ms. Williams' alcohol use symptoms met three criteria
for alcohol dependence. First, she reported using larger amounts of alcohol than she initially
intended, which satisfies Criterion 3 for substance dependence. For example, Ms. Williams
described how she would go to a liquor store to buy "just a six pack" of beer, and then end up
drinking for several days. In addition, Criterion 6 was satisfied because Ms. Williams
reported that she many times was late for work or missed work because of drinking. Finally,
Ms. Williams continued using alcohol despite knowledge that it would cause difficulties in
her interpersonal relationships, which satisfies Criterion 7.
Since Ms. Williams did not report any symptoms of tolerance or withdrawal, the
specifier Without Physiological Dependence was given.
With regard to the overall functioning, Ms. Williams exhibited serious impairment in
several areas of her life. She reported that she was unable to work and financially support
herself due to anxiety and depression symptoms. Additionally, she reported that her intimate
and social relationships suffered because of her alcohol dependence. Based on these
considerations, Ms. Williams's level of functioning was currently assessed at 44.
Based on the above information, the following DSM-IV diagnoses were provided for
Ms. Williams:
AXIS I 300.01 Panic Disorder without Agoraphobia
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296.33 Major Depressive Disorder, Recurrent, Severe Without Psychotic Features
303.90 Alcohol Dependence, Without Physiological Dependence
AXIS II V71.09 No diagnosis
AXIS III None
AXIS IV Break-up with the boyfriend; strained relationship with mother and brother;
inadequate social support; unemployment; inadequate finances and housing.
AXIS V GAF Current- 44




The purpose of this literature review is to provide a general overview of the
empirically supported treatments related to Ms. Williams' diagnoses. The empirical
evidence related to treatment for each diagnosis is reviewed in order of the importance of
the diagnostic symptoms to Ms. Williams. Specifically, treatments for panic disorder are
reviewed first, treatments for major depressive disorder are reviewed second, and
treatments for alcohol abuse and dependence are reviewed third. Since the treatment of
comorbid anxiety and depression represents a separate clinical and research entity, the
section on empirically supported treatments for comorbid panic and major depressive
disorders is also included. In addition, the literature on the treatment of comorbid panic
disorder, major depressive disorder, and alcohol dependence is also reviewed.
Panic Disorder
Panic disorder refers to a clinical syndrome encompassing recurrent, unexpected
panic attacks, persistent concern about having other attacks, worry about the possible
implications or consequences of the panic attacks (e.g., fear of losing control), and/or a
significant behavioral change related to the attacks (e.g., avoiding physical exercise)
(American Psychiatric Association, 2000).
The practice guidelines published by the American Psychiatric Association
specify that cognitive-behavioral therapy and pharmacotherapy are the first-line
treatments for panic disorder (American Psychiatric Association, 1998). In the following
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sections, research literature related to these treatments is explored and a summary of the
literature is provided.
Psychological Treatments of Panic Disorder
A number of psychological models have been developed in an attempt to explain
the etiology of panic attacks and agoraphobia in panic disorder. One of the most
thoroughly developed models is the model that conceptualizes panic disorder as an
acquired fear of bodily sensations and agoraphobia as a behavioral response to the
anticipation of such bodily sensations (Barlow & Cerny, 1988; Clark, 1994; Craske &
Barlow, 2001). According to this model, panic attacks develop as the consequence of
catastrophic misinterpretations of bodily sensations or cognitive processes. For example,
in response to an increase in the heart rate, an individual may think, "I am having a heart
attack." These catastrophic misinterpretations lead to increased anxiety, which in turn
leads to additional, and often more severe, bodily sensations that culminate in a panic
attack. Following repeated attacks, anxiety becomes associated with bodily sensations by
the way of classical conditioning in that even small signs of arousal (e.g., quickened heart
beat) lead to increasing anxiety, eliciting another panic attack. Because the experience of
a panic attack is very unpleasant, the individual begins to experience anxiety about the
recurrence of panic or its consequences. This anticipatory anxiety may lead to
agoraphobic avoidance of situations associated with panic, which helps maintain the
disorder (Margraf, Barlow, Clark, & Telch, 1993; Craske & Barlow, 2001).
Based on the above model, various cognitive-behavioral interventions focusing on
treatment of panic attacks and agoraphobia have been developed. These interventions
include exposure to feared external situations (e.g., going to shopping malls); cognitive
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techniques designed to increase rational appraisals and decatastrophize thinking;
inducing autonomic arousal and panic (i.e., interoceptive exposure) in order to promote
habituation to physiological panic cues; breathing retraining to control breathing and
prevent hyperventilation; and relaxation techniques to reduce physiological reactivity
(Margraf et al, 1994; Willams & Falbo, 1996).
Several studies have investigated the comparative effectiveness of the specific
therapeutic interventions mentioned above (e.g., cognitive restructuring, breathing and
relaxation training, and exposure) used in the treatment of panic disorder (e.g., de Ruiter,
Hanneke, Garssen, & Kraaimaat, 1989; Marks et al., 1993; Bouchard et al., 1996;
Willams & Falbo, 1996; Ito et al., 2001). The results of these studies have generally
demonstrated that different techniques work equally well in reducing the symptoms of
panic attacks and agoraphobia. For example, exposure has been found to be as effective
as breathing retraining (de Ruiter et al., 1989). Additionally, cognitive therapy and
restructuring have been found as effective as exposure (Bouchard et al., 1996; Willams &
Falbo, 1996) and relaxation training (Beck, Stanley, Baldwin, Deagle, & Averill, 1994).
In addition to these separate cognitive-behavioral interventions, two cognitive-
behavioral treatment protocols for the treatment of panic disorder have been developed
that combine several of the interventions into one treatment package. These treatment
protocols are Panic Control Treatment (PCT; Barlow & Cemy, 1988) and Cognitive
Therapy (CT; Salkovskis & Clark, 1991). In the subsequent paragraphs, the research
evidence examining the efficacy of these two treatment protocols is reviewed.
Panic Control Treatment (PCT, Barlow & Cerny, 1988) is one of the most widely
used, researched and empirically validated treatments. PCT is a manualized 15-session
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treatment combining education, cognitive interventions, relaxation and controlled
breathing procedures, and exposure techniques (Hofmann & Speigel, 1999). The efficacy
of PCT for the treatment of panic disorder with limited agoraphobia has been
demonstrated in numerous clinical trials (e.g., Barlow, Craske, Cemy, & Klosko, 1989;
Klosko, Barlow, Tassinari, & Cerny, 1990; Wade, Treat & Stuart, 1998). For example, in
an initial study of PCT, 72 patients with panic disorder were assigned to one of four
groups: PCT treatment consisting of interoceptive exposure and cognitive restructuring,
relaxation alone, relaxation and PCT in combination, or a waitlist control group (Barlow
et al., 1989). The results of this study indicated that the percentage of clients who were
panic free at post-treatment was 87% for PCT in combination with relaxation, 85% for
PCT alone, 60% for applied relaxation alone, and 36% for waitlist controls. Thus, PCT
alone and in combination with relaxation were superior to relaxation alone and a waitlist
condition in reducing panic frequency.
A follow-up study of the clients in the Barlow et. al. (1989) study indicated that
the group receiving PCT treatment alone tended to maintain the treatment gains better
than the groups receiving PCT with relaxation and those receiving relaxation alone.
Specifically, at 2-year follow-up, the percentage of panic-free patients was 81% for PCT
alone, 43% for PCT with relaxation, and 36% for relaxation alone. These results suggest
that the addition of relaxation to standard PCT may reduce the long-term efficacy of PCT
treatment (Craske, Brown, & Barlow, 1991).
In an attempt to investigate the comparative effectiveness of PCT and medication
in treating panic disorder, Klosko et al., (1990) contrasted PCT to alprazolam, a drug
placebo, and a waitlist control using a sample of 57 patients with panic disorder with
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agoraphobia. Results of this study indicated that a significantly greater number of clients
in PCT were panic free at termination of treatment (87%) than clients in both the placebo
group (36%) and waitlist control group (36%) However, the percentage of clients treated
with alprazolam who were panic free at termination (50%) did not differ significantly
from either the PCT or placebo groups. These results suggest that PCT is superior to the
waiting list or drug placebo control groups in the treatment of panic disorder.
The studies described above were conducted using strict research methodology,
and subjects were randomly assigned to treatment conditions (i.e., randomized controlled
trial methodology). While having high internal validity, randomized controlled trials may
not generalize from research clinics to natural settings such as community mental health
centers (CMHC) because of differences in factors such as clients, settings, and therapists,
among others (Wade et al., 1998). In an attempt to investigate how well the results of
randomized controlled trials generalize to natural settings, Wade et al. (1998) explored
the effectiveness of PCT in the treatment of 110 community mental health clinic patients
with a primary diagnosis of panic disorder. The results of this study indicated that after
15 sessions of PCT, 87% of patients were panic-free. Additionally, follow-up measures
collected from the same patients indicated that, at 1-year follow-up, 89% of clients were
still panic-free (Stuart, Treat, & Wade, 2000). Together, these results suggest that not
only can PCT be generalized to naturalistic settings, but also the rates of treatment
success are comparable with the rates obtained in the randomized controlled trials.
Another extensively researched, manualized cognitive-behavioral treatment for
panic disorder is Cognitive Therapy (CT; Salkovskis & Clark, 1991). This 12- sessions
treatment focuses more exclusively on directly changing misinterpretations of bodily
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sensations, incorporates less interoceptive exposure compared to PCT, and does not
include relaxation training (Clark, 1994). Several controlled trials have demonstrated the
efficacy of CT in the treatment of panic disorder. For example, Beck, Sokol, Clark,
Berchick, & Wright (1992) compared CT to supportive psychotherapy using a crossover
design. In this study, 33 patients with panic disorder were randomly assigned to either 12
weeks of CT or 8 weeks of brief supportive psychotherapy based on principles of client-
centered therapy. The patients who received supportive psychotherapy were subsequently
given the opportunity to cross over to CT for 12 weeks. Results of this study indicated
that at 8 weeks, 71% of CT patients were panic-free as opposed to 25% of the patients in
brief supportive therapy. At the end of 12 weeks of cognitive treatment, 94% of CT
patients and 63% of patients who crossed over from supportive therapy were panic free.
Follow-up measures collected from these patients at 1-year indicated that 87% of CT
patients and 79% of brief supportive therapy patients who crossed over to CT were still
panic-free. The results of this study suggest that brief supportive therapy administered
before CT might have interfered with CT for the crossover patients. However, these
patients continued to improve during the follow-up period, thus suggesting the
prophylactic value of CT.
In attempt to investigate the comparative effectiveness of CT and other
psychological and pharmacological treatments, Clark et al., (1994) compared CT, applied
relaxation, imipramine, and a wait-list control group. Participants in the study were 64
patients diagnosed with panic disorder with or without agoraphobia. Participants received
twelve sessions of treatment over 3 months. The results of this study indicated that all
three active treatments were superior to no treatment. Additionally, comparisons among
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active treatments showed that CT was superior to both applied relaxation and
imipramine. Specifically, 90% of patients in CT group were panic free at the end of
treatment, compared to 50% in the relaxation group and 55% in imipramine group. At 6-
months follow-up, CT and imipramine were both superior to applied relaxation (75%,
70% and 40% patients were panic free, respectively), and at 15-month follow-up, CT was
again superior to both imipramine and applied relaxation (85%, 60%, and 47% of panic
free patients, respectively). These results suggest that although the relative efficacy of the
treatments varied with assessment occasion, cognitive therapy was the most consistently
superior treatment.
In summary, ongoing research has documented the clear efficacy of cognitive-
behavioral treatment for panic disorder and agoraphobia. Specific techniques such as
cognitive restructuring, exposure, breathing retraining, and relaxation have been found to
be equally effective in reducing symptoms of panic and agoraphobia. However, two
integrative treatment packages, Panic Control Treatment and Cognitive Therapy, appear
to be the treatments of choice for panic. Specifically, these two treatments have been
shown superior to no treatment and to drug placebo in the treatment of panic disorder. In
addition, PCT and CT have been shown to be superior to pharmacological treatments
(e.g., alprazolam) and to other psychological interventions (e.g., relaxation) administered
alone. The effectiveness of these treatment packages has been demonstrated both at
treatment termination and in long-term follow-up studies. Moreover, PCT has been
shown to generalize well to naturalistic settings, with the rates of treatment success
comparable with those obtained in the randomized controlled trials.
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Pharmacological Treatment of Panic Disorder
Antidepressants and benzodiazepines are the main types of medications that have
been demonstrated to be effective in the treatment of panic disorder (Agras, 1993). In the
following section, the literature supporting the effectiveness of these two types of
medications in the treatment of panic disorder is reviewed.
Antidepressant medications.
Selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs),
and monoamine oxidase inhibitors (MAOIs) are the main classes of antidepressant
medications that have been used in treating panic disorder (Agras, 1993).
The SSRIs have recently become the preferred form of medication for treating
panic disorder due to a number of factors, including that their effectiveness is similar to
older antidepressants such as TCAs and MAOIs, they have fewer side effects and less
prominent withdrawal reactions, and the risk of overdose is lower (Agras, 1993). Results
from recent empirical investigations indicate that SSRIs are effective in the amelioration
of panic symptoms. For example, Lydiard, Steiner, Burnham, & Gergel (1998) cited the
results of three multicenter, double-blind, placebo-controlled studies of paroxetine (i.e.,
Paxil) that demonstrated paroxetine to be significantly more effective than a placebo in
treating symptoms of panic disorder (Ballenger, Wheadon, Steiner, Bushell, & Gergel,
1998; Lecruiber, Bakker, Dunbar, & Judge, 1997; Oehrberg, et al., 1995).
The medications from the second class of antidepressants, tricyclic
antidepressants, have also been shown effective in the treatment of panic disorder (Agras,
1993). For example, Ballenger (1994) cited the results of several controlled investigations
suggesting that imipramine (i.e., Tofranil) is more effective than placebo in reducing
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panic attacks and phobic avoidance (e.g., Sheehan, Ballenger, & Jacobson, 1980;
Lydiard, & Ballenger, 1987; Zitrin, Klein, Woerer, & Ross, 1983). Additionally, Clark
et al., (1994) compared cognitive therapy, imipramine, applied relaxation, and waitlist
control and found imipramine to be superior to no treatment. When relative efficacy of
active treatments was considered at different assessment points, imipramine was found to
be as effective as applied relaxation at post-treatment (50% and 55% of panic free
patients, respectively) and as effective as cognitive therapy at 6-month follow-up (75%
and 70% of panic free patients, respectively).
Although less studied, clomipramine (i.e., Anafranil) also has been shown to be superior
to placebo (e.g., Johnston, Troyer, & Whitset, 1988, cited from Ballenger, 1994).
Despite the effectiveness of TCAs in the treatment of panic disorder, these
medications are often not the drug of choice because of their serious disadvantages. For
example, TCAs have several unpleasant side effects often leading patients to discontinue
treatment prematurely, and their narrow therapeutic range presents a high risk of
accidental overdose. Tricyclic antidepressants have been used less frequently since the
discovery of SSRI medications (Agras, 1993).
There are significantly fewer controlled trials with MAO inhibitors, the third class
of antidepressants used in the treatment of panic disorder. Phenelzine (i.e., Nardil) has
been demonstrated to be effective in a double blind, placebo-controlled trial (Tyrer,
Candy, & Kelly, 1973, cited from Ballenger, 1994) and in the study comparing
phenelzine with imipramine and placebo (Sheehan et al., 1980, cited from Ballenger,
1994). In this study, phenelzine was superior to imipramine on most outcome measures.
Despite these encouraging results, MAO-Is are also not the drug of choice in the
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treatment of panic disorder, mainly because of their side effects, their potential for
serious adverse effects, and the requirement that individuals taking them avoid certain
common foods and beverages.
Benzodiazepines.
The benzodiazepines used most in the treatment of panic disorder are alprazolam
(i.e., Xanax) and clonazepam (i.e., Klonopin). Spiegel (1998) cited two pivotal studies of
alprazolam in the treatment of panic disorder that found statistical superiority of
alprazolam over placebo (Ballenger, et al., 1988; Cross-National Collaborative Panic
Study (CNCPS), Second Phase Investigators, 1992). In addition, alprazolam has been
found to be superior to placebo and as effective as imipramine in reducing symptoms of
panic disorder in studies comparing alprazolam and imipramine (Schweizer, Rickels,
Weiss, & Zavodnick, 1993, cited from Spiegel, 1998).
With regard to the efficacy of clonazepam in the treatment of panic disorder,
Davidson and Moroz (1998) cited the results of two double-blind, placebo controlled
trials of clonazepam in the treatment of panic disorder. Both studies reported that
clonazepam was significantly more effective in reducing symptoms of panic disorder
than placebo (Rosenbaum, Moroz, & Bowden, 1997; Moroz & Rosenbaum, 1999).
Benzodiazepines have many advantages that often make them a drug of choice for
the treatment of panic disorder. For example, they are well tolerated by patients, have a
rapid onset of action, and have a little risk of accidental overdose. However, some
disadvantages of this class of medications should not be overlooked. For example,
benzodiazepines can cause sedation, coordination difficulties, and short-term memory
impairment. Perhaps the most serious adverse effect of benzodiazepines is their high
28
potential for development of physiological and psychological dependence, especially for
people currently dependent on alcohol or drugs.
In summary, several types of pharmacological agents have been shown to be
superior to placebos in the treatment of panic disorder. The use of medications in the
treatment of panic disorder has its advantages such as rapid effect, ease of use, and
accessibility. However, numerous side effects of antidepressants, especially TCAs and
MAO-Is, and a potential ofbenzodiazepines to create dependency are clear disadvantages
to this type of treatment.
Combined Psychological and Pharmacological Treatment of Panic Disorder
Research on combined psychological and pharmacological treatment for panic
disorder is limited and inconclusive. Several studies have investigated the relative and
combined efficacy of psychological and pharmacological treatments of panic disorder
and agoraphobia. For example, Telch and Lucas (1994) conducted a meta-analysis of
eight studies investigating the efficacy of combined psychological and pharmacological
treatments for panic disorder. Results indicated that combined treatments (imipramine
plus exposure or alprazolam plus exposure) had a modest but significant short-term
advantage over psychological and pharmacological treatments alone. However, long-term
effects of combined treatments were less encouraging, as results indicated that although
the majority of patients treated with a combination of imipramine and exposure
maintained the treatment gains at 12-24 months follow-up, the combined treatment was
no more effective than exposure alone.
In contrast to these results, in the study investigating the relative and combined
efficacy of alprazolam and exposure, the combination of alprazolam with exposure
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resulted in higher relapse and poorer long-term outcome than exposure therapy alone
(Marks et al., 1993). In this study, 154 patients were assigned to four groups: alprazolam
plus exposure, alprazolam plus relaxation, placebo plus exposure or placebo plus
relaxation treatment. The treatment lasted 8 weeks, and then medication was tapered to
zero over next 8 weeks. The results indicated that, at the end of eight-week treatment,
clients in all treatment groups demonstrated improvement on panic measures; although,
there were no significant differences between groups. However, at 10 months follow-up,
the proportion of patients maintaining their gains were 62% for placebo plus exposure,
36% for alprazolam plus exposure, 29% for alprazolam plus relaxation, and 18% for
placebo and relaxation. This suggests that not only does discontinuation of alprazolam
result in higher level of relapse compared to exposure, but also that exposure is less
effective when combined with alprazolam.
In another study of the effectiveness of combined treatment for panic disorder,
Sharp et al. (1996) found no statistically significant difference between combined
psychological and pharmacological treatment and each treatment alone. In this study, 190
patients with panic disorder with or without agoraphobia and four active treatment
conditions were compared to a placebo control group. The four active treatment
conditions were Panic Control Treatment (PCT), fluvoxamine (FL), combined PCT and
FL (PCT+FL), and combination of PCT with placebo (PCT+PL). The results indicated
that all active treatments were effective in reducing the symptoms of panic disorder
compared to the placebo group. At the end of treatment, the proportion of panic-free
patients was 70% in PCT group, 68.9% in FL group, 82.7% in FL+PCT group, and
75.7% in PL+PCT group. The differences between active treatment groups were not
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significant. However, the fluvoxamine plus PCT group showed statistically significant
differences from the placebo group two weeks earlier than any other active treatment
group. In addition, this group had the largest proportion of patients noted to have required
no subsequent treatment at the 6-months follow-up. Overall, these results suggest that the
addition of an SSRI medication may enhance the effects of psychological treatment
(Sharp et al., 1996).
In an attempt to investigate short- and long-term effectiveness of single and
combined effects of cognitive-behavioral treatment and imipramine, Barlow, Gorman,
Shear, & Woods (2000) contrasted combined imipramine and PCT treatment to PCT
alone, imipramine alone, PCT plus placebo, and placebo alone. In this study, 312 patients
with panic disorder with and without agoraphobia underwent three months of acute
treatment, and six-months of maintenance treatment. Participants were also followed-up 6
months after treatment discontinuation. Results indicated that both imipramine and PCT
alone were as effective as combined treatment and superior to placebo at the end of acute
phase. At the end of the maintenance phase, the combination of PCT and imipramine was
superior to PCT alone, PCT plus placebo, and imipramine. However, at the 6-months
follow-up, a substantial number of patients taking medication relapsed with the combined
treatment group producing the highest relapse rate. Thus, the addition of imipramine to
psychological treatment resulted in limited benefit over single treatments in the acute
phase and appeared to reduce the long-term durability of CBT after the medication was
discontinued.
In summary, contradictory evidence based on a small number of studies makes it
difficult to arrive at definite conclusions about the efficacy of the combined
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psychological and pharmacological treatments for panic disorder. Combined treatments
seem to have relatively small impact on short-term treatment effectiveness. With regard
to long-term effectiveness, psychological treatments appear to be less effective when
combined with benzodiazepines and tricyclic antidepressants, particularly after
withdrawal of medication. In contrast, SSRIs seem to enhance the long-term impact of
the psychological treatment.
Summary
Based on the literature review, best practice in the treatment of panic disorder
with and without agoraphobia would include manualized treatment packages such as
Panic Control Treatment or Cognitive Therapy. Their effectiveness in the treatment of
panic disorder was supported in controlled and naturalistic studies. Some evidence
indicates that, when used separately, specific techniques such as cognitive restructuring,
exposure, breathing retraining, and relaxation may be less effective than more
comprehensive treatment packages such as PCT and CT.
Antidepressant medications and benzodiazepines have been shown effective in
the treatment of panic disorder. However, their use warrants caution because of the side
effects of all classes of medications, tendency of their therapeutic effects to diminish
rapidly after discontinuation, and, in case of benzodiazepines, high addictive potential.
Combination of cognitive-behavioral therapy and medication in the treatment of panic
disorder does not seem to have short-term advantages over each treatment alone. With
regard to long-term effectiveness of combined treatment, addition of an SSRI appears to
enhance the effectiveness of panic control treatment. In contrast, addition of
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benzodiazepines and TCAs to psychological treatment seems to have a long-term
disadvantage in that it may reduce the long-term effects of psychological treatment.
Major Depressive Disorder
Major Depressive Disorder (MDD) is characterized by the presence of one or
more major depressive episodes in the absence of any manic, hypomanic, or mixed
episodes (American Psychiatric Association, 2000). A major depressive episode is
characterized by the presence of a depressed mood most of the day, nearly every day
and/or the loss of interest or pleasure in almost all activities. In addition to these primary
symptoms, the individual must also experience at least five of the following: disturbances
in appetite, weight, and/or sleep; decreased energy; difficulties in concentrating and
thinking; feelings of worthlessness or guilt; hopelessness and thoughts of death or suicide
or suicidal attempts.
In the following sections, research he effectiveness of various psychological and
pharmacological treatments for major depressive disorder are explored and a summary of
the literature is provided.
Psychological Treatment of Major Depressive Disorder
The most convincing evidence supporting the efficacy of structured
psychotherapies in treating MDD comes from meta-analytic studies. For example,
Robinson, Berman and Neimeyer (1990) reviewed 58 studies conducted to explore the
comparative efficacy of various treatments of MDD. The therapies compared in this
study included behavioral, cognitive, cognitive-behavioral, and general verbal therapies.
General verbal therapy was defined as treatments such as psychodynamic, client-
centered, and interpersonal therapies. Generally, the results of this meta-analysis
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indicated that any therapy was superior to placebo or waitlist controls, with an effect
size of .73 at termination and .68 at follow-up. In regard to efficacy of specific
treatments, results indicated that behavioral, cognitive, and cognitive-behavioral therapies
were moderately effective (1.02, 0.96, and 0.85, respectively), whereas verbal therapies
demonstrated a more modest effect size (0.49). However, after controlling for
investigator's allegiance effects, there remained no differences in the effectiveness of
different types of therapy. These results suggest that psychotherapy in the treatment of
MDD is more effective than no treatment. In addition, different types of therapy seem to
be equally effective in the treatment of MDD.
A second method that has been used to understand the most effective treatment of
MDD has been randomized controlled trials of treatments for depression. One of the most
comprehensive and methodologically sound studies of this sort was the National Institute
of Mental Health' Treatment of Depression Collaborative Research Program (TDCRP)
which examined the differential effectiveness of cognitive-behavioral therapy (CBT),
interpersonal therapy (IPT), and imipramine, which is considered a standard reference
treatment for depression (Elkin et al., 1989). CBT is a structured approach to the
treatment of depression in which patients are trained to identify and modify negative
beliefs and negative interpretations of the past, present, and future (CBT; Beck, Rush,
Shaw, & Emery, 1979). In comparison, IPT focuses on four types of interpersonal
problem categories that are viewed as etiologically related to depression. The focus of
treatment is to help the patient identify and better understand their interpersonal problems
and conflicts and to develop more adaptive ways of relating to others (IPT; Klerman,
Weissman, Rounsaville, & Chevron, 1984).
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In the TDCRP study (Elkin et al., 1989), 239 patients diagnosed with major
depressive disorder were randomly assigned to one of four treatment conditions: CBT,
IPT, imipramine plus clinical management (IMI-CM), or placebo plus clinical
management (PLA-CM). Each treatment was conducted over a 16-week period. The
results of this study indicated that all treatment conditions, including PLA-CM, were
effective in reducing depressive symptoms. Further analysis of the relationship between
initial severity of symptoms and treatment outcome revealed that, for the less depressed
group, there were no significant differences between treatments. However, for the more
depressed group, the patients in the IMI-CM and IPT treatment conditions improved
significantly more than patients in the PLA-CM group. The improvement of patients in
CBT group was not significantly different from patients in the PLA-CM group. With
regard to the comparative effectiveness of IPT and CBT, no significant differences
between these therapies were found. These results suggest that initial depression severity
may be an important factor in considering treatment allocation: less severely depressed
patients may be successfully treated with IPT, CBT, or imipramine. For the more
severely depressed patients, IPT and imipramine appear to be more effective than CBT.
A follow-up study of the 198 TDCRP patients over 18 months (Shea et al., 1992)
showed that only 24% of the patients remained recovered (no MDD relapse) over the 18
months follow-up period. With regard to the proportion of patients who remained
recovered at 18 months, recovery rates in different treatment conditions were 30% of
those receiving CBT, compared with 26% for IPT, 20% for PLA-CM and 19% for IMI-
CM. Among those patients who met criteria for recovery at the end of treatment, but
relapsed during the 18-months follow-up, the relapse rates were 50% for IMI-CM group,
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36% for CBT group, 33% for IPT group, and 33% for PLA-CM group. Despite the
presence of a trend for psychotherapy to be superior to IMI-CM, the differences among
these rates were not significant. The major conclusion from this follow-up study was that
16 weeks of these particular treatments is not a sufficient period to achieve full recovery
and lasting remission for most outpatients with MDD (Shea et al., 1992).
Another attempt to investigate the comparative efficacy of cognitive-behavioral
and psychodynamic/ interpersonal therapy was carried out by Shapiro and colleagues in
the Second Sheffield Psychotherapy Project (Shapiro et al., 1994). In this study, 117
patients diagnosed with major depressive disorder were randomly assigned to either CBT
or IPT treatment according to initial symptom severity (e.g., low, medium, or high) and
treatment length (e.g., 8 or 16 weeks). Results of this study indicated that both therapies
were equally effective and had equivalent results for patients at all three levels of the
symptom severity. However, treatment length was found to interact with initial symptom
level. Specifically, patients with mild or moderate depression had equivalent results with
either 8 or 16 weeks of therapy. In contrast, more severely depressed patients showed
significantly better outcomes when they received 16 weeks of therapy, compared to those
who received only 8 weeks. These results suggest that longer periods of therapy may be
associated with better outcomes for more severely depressed patients
Follow-up of 103 of Shapiro et al. (1994) patients indicated that only 29% of
patients who completed treatment remained recovered (defined as BDI score of 8 or less)
at 1-year follow-up (Shapiro et al., 1995). Of the subjects classified as treatment
responders (defined as BDI score of 8 or less at the end of treatment), 57% maintained
their gains. Equal response rates between the two therapies continued to be present, but
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the interaction between initial symptom severity and duration of treatment was no longer
maintained. However, patients who had eight sessions of IPT appeared to fare less well
than those receiving eight sessions of CBT. In addition, there was a non-significant trend
for patients treated with 16 weeks CBT to maintain the treatment gains to a greater extent
than those treated in the three other combinations. These results suggest that longer
periods of therapy may be associated with better long-term outcomes, particularly in the
case of IPT. In addition, there may be a greater prophylactic effect of CBT compared to
IPT.
In an attempt to investigate the differential effectiveness of CBT and medication,
Hollon et al., (1992) randomly assigned 107 outpatients diagnosed with major depressive
disorder to one of four treatment conditions. The first three conditions were 12 weeks in
length and included imipramine plus clinical management (IMI-CM), cognitive-
behavioral therapy (CBT), and cognitive-behavioral therapy plus imipramine (CBT-IMI).
The fourth treatment group received imipramine plus clinical management (IMI-CM) for
one year after initial 12 weeks period. Results of this study indicated that CBT and
imipramine did not differ in overall efficacy. Unlike in the TDCRP study, no interaction
between initial symptom severity and treatment outcome was found. A 2-year follow-up
of 74 patients from Hollon et al. (1992) study revealed clear differences between
treatments. Patients in 12-weeks IMI-CM group showed the greatest rate of relapse
(50%), and relapse occurred earlier than in other three groups with mean survival time in
the IMI-CM group equal to 3.3 months. In contrast, relapse rates in both CBT and CBT-
IMI groups were 18% with the mean survival time of 17.4 months. In the IMI-CM group
that continued for one year, relapse rate was higher than in CBT (32%) and CBT-IMI
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groups (32%). However, the mean survival time, 17.3 months, was similar (Evans et al.,
1992). These results suggest that even relatively short CBT treatment appears to have a
prophylactic value. However, when generalizing these results, care should be used due to
high dropout rates and small sample sizes at follow-up in this study.
To summarize, research on the psychological treatment of MDD suggests that
although psychotherapy for major depressive disorder is more effective than no
treatment, a substantial number of patients will relapse in the 12-18 months following the
end of the treatment. Two manualized psychological treatments of major depressive
disorder, cognitive-behavioral therapy and interpersonal therapy, have been developed.
These treatments have been shown to have effectiveness similar to that of medication in
the treatment of patients with less severe levels of depression. Research findings
regarding the comparative effectiveness of CBT, IPT and antidepressant medication in
the treatment of more severely depressed patients are inconsistent. Similarly, research
regarding differential effect of initial depression severity on outcomes of patients treated
with CBT or IPT has yielded conflicting results.
Some evidence indicates that although IPT and CBT offered for a brief period of
time may lead to clinically significant improvement in depressive symptoms, longer
periods of therapy may be needed to achieve more lasting effect. In addition, although
CBT and IPT have been shown to be equally effective in the short-term treatment, CBT
appears to have greater prophylactic effect than IPT in that it is associated with longer
periods to relapse.
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Pharmacological Treatment of Major Depressive Disorder
Three types of antidepressants are used most frequently in the treatment of major
depression: selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants
(TCAs), and monoamine oxidase inhibitors (MAO-Is). Considerable research evidence
has accumulated demonstrating the efficacy of all three classes of antidepressants in
treating depressive disorders (Schulberg, Katon, Simon, & Rush, 1999; Williams et al.,
2000; Geddes, Carney, & Davies, 2003).
Results from controlled, double-blind studies indicate that TCAs and MAOs are
effective in the treatment of depression, with 50 to 60 percent of depressed patients
showing significant improvement (Schulberg, et al. 1999; Davis, Wang, Janicak, 1993).
For example, in the review of 300 double-blind, randomized controlled studies of drug
treatment for depression, Davis et al. (1993) concluded that the proportion of depressed
patients who achieved at least 50% improvement in depressive symptoms with TCAs
(65%) was significantly greater than that of patients treated with placebo (37%). These
rates were similar for MAO-Is in that 65% of patients treated with MAO-Is showed
significant improvement compared with 35% of patients treated with placebo. However,
the side effects of TCAs make them less desirable as first-line therapeutic agents
(Speigel, 2003). For example, when patients are treated with TCAs, side effects (e.g.,
sedation, dizziness, dry mouth, increased sweating and palpitations) often lead them to
discontinue their treatment or to reduce the drug dose, which involves a great risk in view
of the high relapse rate and danger of suicide in depression (Speigel, 2003). Similarly,
MAO-Is are also not the drug of choice in the treatment of major depressive disorder,
mainly because of their side effects (e.g., constipation, dry mouth, hypertension, muscle
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aches, nervousness, problems with urination, sedation), their potential for serious
adverse effects, and the requirement that individuals taking them avoid certain common
foods and beverages.
In contrast, SSRIs have fewer side effects, and the side effects are better tolerated
by patients (Nemeroff, 1994). The side effects of SSRIs may include sexual inhibition,
weight gain, nausea, and headaches. The effectiveness of SSRIs in the treatment of
depression has been supported by a number of studies. For example, the results of the
recent review of 315 double-blind, randomized placebo-controlled trials of SSRIs in
treating depression indicated that SSRIs were significantly more efficacious than placebo
(Williams et al., 2000). Overall, 51% of patients experienced at least 50% improvement
in depressive symptoms compared to 32% of patients who received placebo. In addition,
results of this review indicated that SSRIs had the same effectiveness as TCAs and
MAO-Is in reducing symptoms of depression. Fifty four percent of patients who received
an SSRI and 54% of those who received a TCA or MAO-I experienced at least 50%
improvement in depressive symptoms.
In an attempt to investigate the long-term efficacy of pharmacological treatments
of depression, Geddes at el. (2003) conducted a review of 31 randomized controlled trials
of antidepressants. All trials investigated the effectiveness of continuing antidepressant
therapy into various maintenance therapy periods after the remission of the major
depressive episode. The maintenance periods in the studies investigated ranged from 6 to
36 months. Results indicated that, overall, the rate of relapse for patients who continued
to take antidepressant medication for 6 to 36 months after achieving remission of the
acute depressive episode was significantly lower (18%) compared to patients taking
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placebo (41%). The treatment effect was similar across different classes of
antidepressants.
In summary, double-blind, randomized controlled studies showed several types of
pharmacological agents to be effective in the treatment of major depressive disorder.
TCAs, MAO-Is, and SSRIs have been shown to be superior to placebo in reducing
depressive symptoms in both short-term and long-term trials. Moreover, the rates of
improvement have been shown to be similar for patients treated with different classes of
antidepressants. Despite similar effectiveness, TCAs and MAO-Is are no longer the
treatment of choice because of their toxicity and adverse effects. On the other hand, the
better tolerability and lower side effect profile of SSRIs make them a first-line
pharmacological treatment for depression.
Combined Psychological and Pharmacological Treatment of Depression
Research on the effectiveness of combined psychological and pharmacological
treatment for depression has produced contradictory findings. One of the first studies to
evaluate the concurrent use of pharmacotherapy and psychotherapy was conducted by
Blackburn, Bishop, Glen, Whalley, and Christie (1981). In this study, 64 patients
diagnosed with major depressive disorder were randomly assigned to either cognitive
therapy, TCA antidepressant medication (amitriptiline or clomipramine), or a
combination of cognitive therapy and medication. The results of this study indicated that
the combination of cognitive therapy and medication was superior to either treatment
alone. Specifically, results indicated that 79% of the combination group showed a
significant improvement (as measured by the BDI) at the end of treatment, compared
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with 59 % of the medication group and 48% of the cognitive therapy group. The severity
of depression did not have an impact on the outcome for either treatment.
A 2-year follow-up of the patients from Blackburn et al. (1981) study revealed a
different pattern of results: 78% of patients in the medication group relapsed, compared
to 23% in the CT group and 21% patients in the combined treatment group. The
difference between the medication group and the two CT groups was significant,
suggesting a prophylactic effect of CT, either alone or in combination with medication
(Blackburn, Eunson, & Bishop, 1986). The results of these studies suggest that, although
an addition of medication appears to enhance the effect of cognitive therapy in the short-
term treatment, it does not have a significant additive effect on the maintenance of
treatment gains.
Another study provided evidence suggesting the superiority of combined IPT and
pharmacotherapy to CBT or IPT alone. Thase et al. (1997) performed a meta-analysis of
pooled data of 595 depressed patients from 6 studies investigating the effectiveness of
CBT, IPT, or IPT in combination with medication. In this study, the superiority of IPT
combined with medication was particularly evident in the treatment of more severe,
recurrent depression. Specifically, in less severely ill patients, no significant differences
were seen between single treatments (37% of improved patients) and combined
treatments (48% of improved patients). For more severely depressed patients, however,
remission rates were significantly higher with combined treatments (43%) than with
psychotherapy alone (25%). These results suggest that for more severely depressed
patients, combined IPT psychotherapy and medication can enhance the treatment
effectiveness compared to either IPT or CBT psychotherapy alone.
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In attempt to examine long-term effectiveness of combined treatment, Reinolds
et al. (1999) investigated the efficacy of combined treatment with interpersonal therapy
and nortriptyline in maintenance of treatment gains in depression. In this study, 107
elderly patients who recovered from a major depressive episode were randomly assigned
to four maintenance treatment conditions: IPT and nortriptyline, nortriptyline and
medication clinic, placebo and IPT, and placebo and medication clinic. Results of this
study indicated that, at the end of 3-year maintenance treatment, all three active
treatments were superior to placebo plus medication clinic condition. With regard to the
effectiveness of three active treatment conditions in preventing recurrence of depression,
combination treatment was superior to IPT alone but not to nortriptyline. The relapse
rates were 64% for the IPT group, and 43% for nortriptyline group, compared to 20% for
combination group. These results suggest an advantage of combined psychotherapy and
pharmacotherapy over psychotherapy alone in maintenance of treatment gains in elderly
patients recovered from depression.
Despite these promising results, conclusions from other studies regarding the
advantages of combined therapy over either therapy alone are less definitive. For
example, in an early trial, Murphy, Simons, Wetzel, & Lustman (1984) randomly
assigned 87 patients with major depressive disorder to 12 weeks of either cognitive
therapy (CT), nortriptyline, combination of these treatments, or CT and placebo. Results
of this study indicated that at the end of treatment, a significant improvement of
depressive symptoms (as measured by BDI) was evidenced in 78% of combined CT and
medication patients, 65% of CT and placebo patients, 56% of nortriptyline patients, and
53% of CT patients. Although the number of improved patients was highest in the
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combined group, the difference between combined group and other groups did not
approach significance. These results suggest that the combination of treatments did not
lead to additive effects over either psychotherapy or medication.
Similarly, Hollon et al. (1992) found no advantage of combined psychotherapy
and pharmacotherapy over single treatment. This study investigated the differential
effectiveness of combined CBT and imipramine treatment compared to CBT and
medication alone. These researchers found no significant differences in effectiveness
between imipramine, CBT, and their combination in reducing symptoms of depression.
Moreover, patients with different levels of depression severity responded equally to all
three treatments. A 2-year follow up of the patients of Hollon et al. study indicated that
the difference in relapse rates in combined therapy group and CBT group was not
significant (15% and 21% of relapsed patients, respectively). Patients treated with
imipramine alone differed significantly from both CBT and combined groups and had a
50% rate of relapse (Evans et al., 1992). These results suggest that adding
pharmacotherapy to psychotherapy does not have an advantage over psychotherapy
alone.
In summary, contradictory research evidence on effectiveness of combined
psychological and pharmacological treatment for depression makes it difficult to arrive at
definite conclusions regarding the advantage of combining psychotherapy and
pharmacotherapy in the treatment of depression. It appears that patients with less severe
depression may be treated successfully with either interpersonal therapy or cognitive-
behavioral psychotherapy alone. With regard to patients with more severe levels of
depression, it seems that the addition of a TCA may enhance the treatment effectiveness
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when these patients are treated with interpersonal therapy. In contrast, when these
patients are treated with cognitive-behavioral therapy, it appears that the addition of a
TCA to the cognitive-behavioral treatment does not have an advantage over CBT alone.
Summary
Based on the literature review, best practice in the treatment of major depressive
disorder would include at least 16 weeks of structured psychotherapy, such as cognitive-
behavioral therapy or interpersonal therapy and pharmacotherapy. CBT or IPT alone
seem to be sufficient when treating clients with mild to moderate degree of depression
severity. These treatments have been shown to be as effective as medication in the
treatment of patients with less severe levels of depression.
With regard to pharmacotherapy, SSRIs appear to be the best pharmacological
treatment for depression. The effectiveness of these medications is comparable to the
effectiveness of older medications such as TCAs and MAO-Is, and their better
tolerability and lower side effect profile make them a treatment of choice. In addition,
similarly to TCAs and MAO-Is, the effectiveness of SSRIs have been shown in both
short-term and long-term trials. Treatment with TCAs and MAO-Is is warranted when a
client does not respond to the treatment with SSRIs.
Combined psychotherapy and pharmacotherapy appears to be indicated in the
treatment of more severely depressed clients, especially when using interpersonal
therapy. An addition of a TCA to the cognitive-behavioral treatment warrants caution,
given the absence of compelling evidence of superiority of combined CBT and TCA
pharmacotherapy over CBT alone.
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Alcohol Dependence
Alcohol dependence is characterized by a maladaptive pattern of alcohol use
leading to clinically significant impairment or distress as indicated by the presence of
three or more alcohol use symptoms occurring at any time in the same 12-months period.
The first two symptoms of alcohol dependence specified in the DSM-IV-TR criteria are
tolerance and withdrawal. Tolerance is defined as a need for markedly increased amounts
of alcohol to achieve intoxication or the desired effect, or markedly diminished effect
with continued use of the same amount of alcohol. Alcohol withdrawal is defined as the
presence of two or more of the following symptoms after cessation of, or reduction in,
heavy and prolonged alcohol use: autonomic hyperactivity, increased hand tremor,
insomnia, nausea or vomiting, transient hallucinations, psychomotor agitation, anxiety,
grand mal seizures). Other symptoms of substance dependence may include: drinking
larger amounts or over longer periods of time than was intended; a persistent desire or
unsuccessful efforts to cut down or control drinking; a great deal of time spent in
activities necessary to obtain alcohol, drink, or recover from its effects; important
activities are given up because of alcohol use; and drinking is continued despite
knowledge of having persistent psychological or physical problems caused by alcohol
use (American Psychiatric Association, 2000).
In the following section, the literature on empirically supported psychosocial and
pharmacological treatments for alcohol dependence is reviewed and the summary of the
literature is provided.
Psychosocial Treatments for Alcohol Dependence
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Several reviews of alcohol treatments have identified effective approaches for
the treatment of alcohol dependence and abuse. For example, Miller and Hester (1986)
reviewed controlled outcome research related to the treatment of alcohol dependence.
The results of their review identified several effective treatment approaches. These
approaches were aversion therapies, skills training, community reinforcement
approaches, and marital and family therapy. In another review of treatments for alcohol
dependence and abuse, Holder, Longabaugh, Miller, and Rubonis (1991) identified
effective treatments taking into account their cost to implement. In this review, the
approaches with good evidence of effectiveness and relatively low cost were brief
interventions, skills training, marital behavioral therapy, and community reinforcement.
In the most recent review (Miller et al., 1995), the treatment outcome literature was
summarized while taking into account the methodological quality of the studies, which
makes the results of the review more valid. Based on the results of this review, the
treatment approaches that have the strongest evidence supporting their effectiveness
include brief interventions, motivational enhancement strategies, and broad spectrum
skill training, including coping and social skills training and community reinforcement.
In the following section, the literature on brief interventions, motivational enhancement
strategies, and broad-spectrum skill training are reviewed and a summary of the literature
regarding their efficacy is provided.
Brief interventions.
Among approaches that have been investigated as treatments for alcohol
problems, brief interventions have been one of the most thoroughly investigated (Miller
et al., 1995). Brief interventions vary in length from a few minutes to three sessions.
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They usually have several common components, including assessment of drinking
behavior and providing feedback about effects of drinking on client's life, encouraging
client's responsibility for change, offering advice to reduce or stop drinking, providing a
menu of alternative strategies for reducing drinking, using an empathic approach and
reinforcing client's self-efficacy (Bien, Miller, & Tonigan, 1993; Brown, 2001). The
primary targets for brief interventions are individuals who drink above suggested
guidelines for safe drinking, but are not alcohol dependent and individuals with low
levels of alcohol dependence (Brown, 2001).
Several studies have compared brief interventions to no treatment. In the first
clinical trial of this kind, 585 problem drinkers with high scores on liver enzyme (GGT)
indicative of heavy drinking were randomly assigned to either a brief intervention or
control condition. The brief intervention group was counseled to moderate their drinking
habits by a physician. After their initial appointment, they met with a nurse every month
and a physician every four months for four years. Individuals in the control condition
received no treatment and were followed-up every other year. Results of this study
indicated that over 6 years of follow-up, the GGT values in both groups had significantly
decreased, with no difference evident between the groups. However, significant
differences were observed between the two groups with regard to sick absenteeism,
hospitalization, and mortality. The individuals in the brief intervention group had 80%
fewer sick days, 60% less days in the hospital, and 50% fewer deaths than individuals in
the control condition. These results suggested that a brief treatment program might be
effective in preventing medico-social consequences of heavy drinking (Kristenson, Ohlin,
Hulte-Nosslin, Trell, & Hood, 1983).
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Another attempt to compare brief interventions to no treatment was carried out
by Wallace, Cutler, and Haines (1988). In this study, brief intervention was defined by
advice to reduce drinking given by a general medical practitioner. Participants were 709
heavy-drinking patients who were randomly assigned to either advice group or control
group. The results of this study indicated that, at 1-year follow-up, 46% of patients in the
advice group significantly reduced their alcohol consumption, compared to 27% of
patients in the control group (Wallace et al., 1988, cited from Heather, 1995). These
results suggest that even brief intervention such as advice to reduce alcohol consumption
may be effective in reducing drinking behavior.
Several studies investigated the comparative effectiveness of brief interventions
and more extensive treatments. For example, a pioneering trial in this area was Orford
and Edwards's (1977) study of 100 male married problem drinkers. After a
comprehensive three-hour assessment of alcohol consumption patterns and their effect on
subjects' life, the participants were randomly assigned either to extensive treatment or to
a single session of advice. The extensive treatment lasted several months and consisted of
a mixture of outpatient and inpatient, psychiatric and social work care. An advice session
consisted of a 60-minutes counseling session with a psychiatrist. The results atl and 2
year follow-up indicated that patients in both groups significantly improved on most
outcome measures, including drinking behavior, alcohol-related problems, and social
adjustment. No significant differences between treatments were found on any of the
outcome measures (Orford & Edwards, 1977, cited from Heather, 2001). This lack of
differences in outcomes was repeated in a follow-up of this cohort 12 years after entry to
treatment, suggesting that many of alcohol dependent patients do not need prolonged and
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relatively expensive treatment programs to show marked and sustained improvements in
drinking behavior. (Edwards, Duckitt, Oppenheimer, Sheehan, & Taylor, 1983).
Orford and Edwards's (1977) study was criticized on several grounds. Some of
the criticisms were that the findings of this study were not likely to generalize to female
populations and that married and socially stable drinkers without significant psychiatric
disturbance in this study had a generally good prognosis regardless of what treatment was
provided. Thus, they were more likely to benefit from the brief intervention than
unmarried or less socially stable individuals who are often seen in treatment (Heather,
2001).
In an attempt to overcome methodological limitations of Orford and Edwards's
(1977) study, Chick, Ritson, Connaughton, Stewart, and Chick (1988) attempted to
replicate their findings using a modified design. In this study, 152 male and female,
married and unmarried patients at an alcohol clinic were randomly allocated to extended
inpatient or outpatient treatment or to one of two forms of brief interventions. The first
brief treatment group received "simple advice," consisting of no more that 5 minutes
standardized advice to stop drinking. The second group received 30-60 minutes of
"amplified advice" in which a psychiatrist tried to increase the client's motivation to
make a radical change in drinking behavior. Results of this study indicated that, at 2-year
follow-up, there was no difference between extended treatment and advice groups in
abstinence rates, employment, or marital status. For example, the number of abstinent
days was increased in 73% of the extended treatment group and 67% of the advice only
group; 75% of the extended treatment and 72% of the advice only group remained
employed; and 69% of the extended treatment and 68% of the advice only group were
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still married. In addition, no differences were observed between the simple and
amplified advice groups. However, the extended treatment group was experiencing less
harm from their drinking during the follow-up period. The results of this study suggest
that abstinence or problem-free drinking that is achieved in the standard treatment
program can be achieved with much briefer and less expensive treatment However, the
question still exists regarding the long-term outcome of such interventions, as the results
of this study failed to support the long term benefit of brief interventions with regard to
harm experienced from drinking.
Motivational enhancement.
Motivational enhancement strategies seek to initiate a client's intrinsic motivation
to change. Central to this approach is understanding of the client's ambivalence about
change and using encouragement and empathy to discover what makes it worthwhile to
change (Brown, 2001).
Interventions guided by motivational enhancement strategies have often followed
the format of a "Drinker's Check-Up" (DCU; Miller, Sovereign, & Krege, 1988). This
intervention consists of two stages. First, drinking behavior and its effect on a drinker's
physical health and family life are assessed. Then, the results of this assessment are
presented to the client in the feedback session where the client is encouraged to change
his/her drinking behavior through the use of motivational interviewing strategies (Miller
& Rollnick, 1991).
Several studies have been conducted to evaluate motivational enhancement
approaches. For example, Bien (as cited in Bien et al., 1993), examined how the addition
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of a motivational intervention to a standard inpatient treatment for alcohol dependence
influences the outcomes of treatment. In this study, 32 participants were randomly
assigned to either a DCU or to no intervention prior to entering outpatient treatment.
Results at 3-months follow-up indicated that patients receiving the motivational interview
reported significantly less drinking and more abstinent days compared to those who
received no additional intervention. These results suggest that motivational induction
may enhance the results of traditional treatment.
Using a similar design, Brown & Miller (1993) randomly assigned 28 clients
admitted to a residential substance abuse program to receive or not receive a DCU prior
to entering treatment. Results of this study indicated that clients who received
motivational induction were more fully involved in the treatment (by therapist's blind
ratings), and they had significantly lower levels of alcohol consumption 3 months after
discharge.
Additional evidence regarding the effectiveness of motivational enhancement
strategies comes from the results of Project MATCH, the largest study of the treatments
for alcohol problems ever carried out (Project MATCH Research Group, 1997a, 1997b,
1998). The goal of the study was to match patient characteristics with several different
psychotherapeutic approaches in order to obtain optimal patient-to-treatment matching. A
total of 1726 clients were divided into two parallel but independent clinical trials. One
trial was conducted with alcohol dependent patients receiving outpatient therapy. The
other trial was conducted with alcohol dependent patients receiving aftercare therapy
following inpatient or day hospital treatment. Clients within each arm were randomly
assigned to one of three 12-week, manual-guided interventions: Twelve-step Facilitation
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Therapy (TSF), an approach following the principles of Alcoholics Anonymous;
Cognitive-behavioral Coping Skills Therapy (CBT), with emphasis on overcoming social
and coping skills deficits; and Motivational Enhancement Therapy (MET) which
employed motivational strategies to mobilize the individual's own resources. CBT and
TSF consisted of 12 weekly sessions, while MET consisted of four sessions spread over
12 weeks. The results indicated that all three treatments resulted in significant reductions
in the number of abstinent days and in the number of drinks per drinking day. However,
there were no statistically significant differences among treatments. These results were
consistent across the entire range of clients in the sample and applied not only to clients
with fewer symptoms of dependency or of lesser problem severity. These findings
suggest that, although delivered in a fewer number of sessions, motivational enhancement
is comparable in effectiveness to two other manualized and more intensive treatments,
twelve-step facilitation therapy and cognitive-behavioral therapy.
Broad spectrum skills training.
"Broad spectrum" treatment approaches place a primary focus not on alcohol
consumption per se but on life problem areas often functionally related to drinking and
relapse. Among skill training treatments for alcohol problems, coping and social skills
training and community reinforcement approaches have the strongest empirical support
(Miller et al., 1995).
With regard to the coping and social skills training, the underlying assumption of
this treatment approach is that drinking problems arise because the individual lacks
specific coping skills for sober living, including a lack of skills to regulate mood states
53
and to cope with interpersonal situations, including work, parenting, or marital
relationships (Monti, Rohsenow, Colby, & Abrams, 1995). Coping and social skills
training includes interpersonal skills training for building better relationships, cognitive-
emotional coping for mood regulation, coping skills for dealing with stressful life events,
and coping in the context of substance use cues.
Numerous studies have investigated the effectiveness of skills training in the
treatment of alcohol dependence. For example, Chaney O'Leary, & Marlatt (1978)
assigned clients receiving standard inpatient treatment to one of three groups:
assertiveness training, emphasizing the analysis of problematic situations and practicing
assertive responses in these situations; discussion control, where patients were
encouraged to express and discuss personal feelings about these same situations without
practicing new responses; and a no additional treatment control group. The results at one-
year follow-up indicated that, compared to both control groups, the patients in the
assertiveness training group had six times less drinking days. In addition, they consumed
four times less alcohol than controls when they did drink, and the drinking period was
eight times shorter. The differences between the assertiveness training group and both
control groups were significant. These findings suggest that social skill training was
superior to traditional inpatient treatment in the treatment of alcohol dependent patients.
Oei and Jackson (1980, 1982) attempted to further explore the effectiveness of
skills training in the treatment of alcohol dependence in a series of studies. In the first
study, 32 alcoholics were randomly assigned to 12 sessions of either social skills training
or traditional supportive therapy treatment, with each condition delivered in both
individual and group formats (Oei & Jackson, 1980). Results indicated that individuals in
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both group and individual social skills training experienced significantly greater
reductions in alcohol consumption and greater improvements in social functioning
throughout a 12 months follow-up period in comparison to both individual and group
traditional supportive therapy. Additionally, patients in group skills training demonstrated
improvement in social skills earlier in the course of treatment than did patients in
individual training, with equivalent reductions in drinking. These results suggest that
social skills training may be more effective than traditional supportive psychotherapy.
This may be particularly true when social skills training is provided in a group format
In the second study, Oei and Jackson (1982) expanded the findings from their first
study. Participants in this study were 32 hospitalized alcoholics with mild to severe
assertiveness deficits. They were randomly assigned to one of four treatment
combinations: social skills training using role playing, videotaping, feedback, and
homework assignments; cognitive restructuring encouraging positive self-talk and
attempting to modify irrational beliefs; both of those treatments combined; and traditional
supportive therapy. The treatment consisted of 12 group sessions conducted over a 3-
week period. Results indicated that, at 12-months follow-up, clients from the traditional
supportive therapy group had significantly poorer social and assertion skills and
evidenced significantly less improvement on alcohol consumption measures than clients
in the other three groups. When administered alone, social skills training led to greater
immediate improvements, whereas cognitive restructuring alone and in combination with
social skills training was associated with better maintenance of treatment gains at later 3,
6 and 12 months follow-up intervals. The results of this study suggest that social skills
training, cognitive restructuring, and their combination all appear to provide effective
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treatments for alcohol dependent clients with assertiveness deficits. However, cognitive
restructuring in combination with social skills training results in the greatest long-term
benefit.
Another skill training approach that has been shown to be effective in the
treatment of alcohol dependence is the Community Reinforcement Approach (CRA, Hunt
& Azrin, 1973). CRA attempts to restructure clients' environments so that the rewards
associated with alcohol use are reduced and the costs of excessive drinking are increased.
The treatment consists of several components, including communication training,
learning how to find and keep a job, helping the client develop satisfying social and
recreational activities that compete with alcohol use and support sobriety, relationship
counseling, and instruction in relapse prevention strategies. CRA is appropriate for
individuals who are striving for either lifelong abstinence or moderation (Smith &
Meyers, 1995).
The effectiveness of CRA has been demonstrated in several controlled trials. For
example, Hunt & Azrin (1973) conducted a matched control study with 16 patients
undergoing standard inpatient treatment for alcohol dependence. For participation in the
study, eight patients were selected arbitrarily, and then matched individually with eight
others on the basis of employment history, family stability, previous drinking history,
age, and education. By a coin flip, one member of each pair was assigned to receive CRA
counseling in addition to their standard treatment program, whereas the other member
received no additional intervention. Results indicated that, throughout a 6-months follow-
up, subjects who received CRA treatment were drinking on 14% of days, compared to
79% of drinking days for control patients. Unemployment days were 12 times higher in
56
the control group, and controls spent 15 times more days in institutions. In addition, all
marriages in the CRA group remained intact, whereas 25% of marriages ended in
separation or divorce for the control group. These results suggest that CRA is superior to
a standard treatment approach to the treatment of alcohol dependence.
In another matched control study of 18 inpatients, Azrin (1976) used an improved
version of CRA. This version included administration of disulfiram, a medication
designed to help prevent relapse after abstinence has been achieved; a behavioral
program aimed to increase disulfiram compliance; daily self-monitoring of mood as an
early warning system for relapse; and a "buddy" system as a source of continued social
support. This package was compared to standard hospital treatment. Results indicated
that, during a 6 months follow-up, the percent of days spent drinking averaged 2% for the
CRA group and 55% for control group. In addition, 20% of CRA group was unemployed
compared to 56%'of the control group. Significant differences also were found for the
number of days spent away from one's family and for the number of days spent
institutionalized. These results were stable over a 2-year follow-up period, with CRA
clients showing more than 90% abstinent days at 12, 18, and 24 months. These results
suggest that the CRA has a long-term protective benefit.
In summary, research has documented the efficacy of several approaches to the
treatment of alcohol problems. Brief interventions such as advice to reduce alcohol
consumption have been shown to be effective for individuals abusing alcohol and for
those with low levels of alcohol dependence. For these populations, brief interventions
have been shown to be more effective than no treatment and to have the same efficacy as
more extensive treatments.
57
Additionally, motivational enhancement strategies, such as Drinker's Check -Up
and motivational interviewing have been shown to enhance the results of standard
inpatient and outpatient alcohol treatment and to be comparable in effectiveness to more
intensive treatments such as twelve-step facilitation therapy and cognitive-behavioral
therapy.
Finally, broad spectrum skill training, such as social and coping skills training and
community reinforcement approach has been shown to be superior to traditional inpatient
treatment.
Pharmacological Treatmentsfor Alcohol Dependence
Pharmacological treatments for alcohol dependence are not intended to be a
primary treatment, but are to be used as part of a multimodal treatment program to help
patients avoid drinking while they are restructuring their lives (Fuller, 1995). Two classes
of pharmacological agents have been shown to be effective adjuncts in the treatment of
alcohol dependence. These are opioid antagonists and acamprosate.
Among the opioid antagonists, naltrexone (i.e., Nalorex) has been shown to be
efficacious in preventing relapse in alcohol dependent patients. Naltrexone is thought to
suppress the positive, reinforcing effects of ethanol by blocking the transmission of the
brain's own opiate transmitters that are involved in producing the pleasurable effect
associated with alcohol consumption (Chick, 2001). Results from placebo-controlled
trials have consistently revealed that the only one adverse effect of this medication is
nausea (Chick, 2001).
Several studies have examined the effectiveness of naltrexone as an adjunct in the
treatment of alcohol dependence. For example, Volpicelli, Alterman, Hayashida, and
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O'Brien (1992) conducted a double-blind, placebo-controlled study of naltrexone in 70
male alcohol dependent inpatients undergoing a comprehensive psychosocial treatment
following alcohol detoxification. In addition to the standard treatment, study participants
were randomly assigned to treatment with either naltrexone or placebo. Results indicated
that, at the end of 12-weeks treatment, significantly fewer of the naltrexone-treated
patients (23%) relapsed, compared to patients in the placebo group (54%). In addition,
those individuals in the naltrexone group reported significantly less craving than the
individuals in the placebo group. These results suggest that naltrexone appears to be an
effective adjunct to the treatment of alcohol dependence.
Another pharmacological agent that has been shown effective in alcohol relapse
prevention is acamprosate (i.e., Campral EC). Acamprosate is thought to reduce
glutamate transmission in the brain. The excess of glutamate in the brain's reward system
is believed to lead to sub-acute withdrawal symptoms that trigger drinking in the patient
who is withdrawn from alcohol. Acamprosate alters the sub-acute withdrawal state,
thereby reducing drinking (Chick, 2001). With regard to side effects of acamprosate, mild
diarrhea and abdominal discomfort have been reported (Chick, 2001).
The effectiveness of acamprosate compared to a placebo control group has been
well documented (Chick, 2001). For example, the first randomized controlled study of
acamprosate in recently detoxified patients found that 33% of acamprosate-treated
patients relapsed during the 3-month outpatient treatment period, compared to 66% of
placebo patients (Lhuintre et al., 1985). In addition, Chick (2001) cited the results of
other large randomized controlled studies (e.g., Whithworth et al., 1996; Sass, Soyka,
Mann, & Ziegelgansberger, 1996; Poldrugo, 1997) that have shown acamprosate
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efficacy. In these studies, the proportion of patients achieving complete abstinence with
acamprosate typically was approximately two times greater than proportions of patients
who achieved complete abstinence with placebo. These studies also found that the
cumulative total number of days abstinent was significantly greater in the acamprosate-
treated patients.
In summary, naltrexone and acamprosate have been shown to be effective
adjuncts to the treatment of alcohol dependence. These medications have been shown to
be superior to a placebo in preventing relapse in patients diagnosed with alcohol
dependence. Naltrexone and acamprosate do not result in potentially harmful effects if
the patient ingests alcohol. In addition, neither drug has serious side effects.
Summary
Based on the literature review, there does not seem to be any one-treatment
approach adequate to the task of treating all individuals with alcohol problems. Best
practice in the treatment of alcohol dependence would be a multimodal therapeutic
approach comprising psychosocial and pharmacological treatments and tailored to the
needs and characteristics of each individual client. Psychosocial treatments should
include brief interventions, motivational enhancement strategies, and broad spectrum
skills training. Specific types of skills that might be provided include social and coping
skills training and community reinforcement. The efficacy of these treatment approaches
has been established in comparison to the standard inpatient and outpatient treatment.
Pharmacological treatments such as naltrexone and acamprosate can be used in
conjunction with psychosocial approaches to help a client to establish a change in
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lifestyle. Results of research to date suggest that these medications are effective in
preventing relapse in alcohol dependence in comparison to placebo.
In closing, it is important to note that most of the alcohol dependence treatment
studies investigated the effectiveness of treatments in comparison to placebos or standard
treatment. Virtually no studies systematically examined the comparative effectiveness of
various treatment approaches. Therefore, the conclusions regarding the effectiveness of
these treatments should be considered tentative until more definitive conclusions can be
gleaned from the literature.
Comorbid Panic Disorder and Major Depressive Disorder
Research evidence suggests that major depression is frequently and systematically
associated with panic disorder (Grunhaus, 1994). According to some estimates, one-third
to one-half of patients presenting with one disorder have some symptoms of the other
(Johnson & Lydiard, 1998). The two conditions may occur together during the index
episode or they may appear at different times. For example, depression appears to be
secondary to panic disorder or agoraphobia with panic attacks in approximately 70% of
patients with comorbid panic disorder and major depressive disorder, and panic disorder
is secondary to major depression in the remaining 30% of patients (Grunhaus, 1988).
Growing evidence suggests that patients with comorbid panic disorder and major
depression may have a more severe illness and may be at greater risk for poor treatment
outcomes. For example, Coryell et al. (1988) analyzed the clinical.symptoms and the
course of illness in 91 patients diagnosed with depression with panic attacks and panic
disorder with major depressive disorder. These data were compared to the data of 417
patients with only major depression. The treatment in this study was an antidepressant
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medication. All patients were assessed with Longitudinal Interval Follow-up Evaluation
(LIFE; Keller, Lavori, & Friedman (1987) at 6, 12, 18, and 24 months after the beginning
of treatment. In addition, treatment was monitored through weekly reviews of medical
records. Results indicated that depressed patients with panic attacks had significantly
more severe depressive symptoms at intake and at 24-months follow-up than patients
with depression alone. Moreover, significantly fewer depressed patients with panic
attacks (75.3%) and panic disorder patients with secondary major depression (71.4%)
recovered over the follow-up period compared to those with depression alone (86.1%). In
addition, 66.7% of individuals with panic disorder and secondary major depression
experienced work impairment compared to 28.7% of patients in the major depression
alone group and 28% in the major depression with secondary panic attacks group.
Grunhaus, Pande, Brown, and Greden (1994) provided additional evidence
suggesting that comorbid conditions are more severe than pure clinical conditions.
Participants in this study were 119 patients with major depression alone and 57 patients
with major depression and comorbid panic disorder. Participants were assessed with the
Schedule for Affective Disorders and Schizophrenia (SADS; Endicott & Spitzer, 1978).
In addition, all available past medical records were reviewed. Results indicated that,
compared to patients in depression only group, patients with comorbid panic disorder and
depression experienced more severe symptoms during the current episode of illness,
reported symptoms earlier in life, sought treatment at younger age, and required
hospitalization earlier and more frequently. In addition, patients in the comorbid group
experienced more feelings of inadequacy, symptoms of somatic anxiety, and phobic
symptoms than patients in depression only group.
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The results of these studies suggest that comorbid panic disorder and major
depressive disorder is a more complicated clinical condition compared to each disorder in
its "pure" form. Therefore, the treatment of comorbid disorders may require a different
treatment strategy. In the following section, the literature examining psychological and
pharmacological treatment for comorbid panic disorder and major depressive disorder is
reviewed and a summary of the literature is provided.
Psychological Treatment of Comorbid Panic Disorder and Major Depressive Disorder
At the present time, there are no psychological treatments designed specifically
for the treatment for comorbid panic disorder and major depressive disorder. In addition,
only few studies have examined the treatment outcomes in patients with comorbid
disorders. For example, in a preliminary study, Laberge, Gauthier, Cote, Plamondon, and
Cormier (1993) attempted to determine whether or not patients with comorbid panic and
depression could be treated as successfully as patients with panic disorder only.
Participants were eight subjects with comorbid panic disorder and major depression and
seven subjects with only panic disorder. The treatment was a two multiple baseline A-
A1-A-B across subjects design. In baseline A, subjects monitored their panic attacks
daily. During the Al phase, a program of information on panic attacks presented as
psychotherapy was instituted. This was followed by a second baseline phase (A). Finally,
CBT for the treatment of panic disorder (B) was introduced. Treatment lasted 15
sessions, and subjects were assessed 1, 3, and 6 months after the end of treatment. The
results of the study indicated that at the end of 15-weeks CBT treatment, all patients in
both comorbid and panic disorder only groups were panic free, and 87% of them were
still panic free at the 6-month follow-up. Patients who were not panic free at the 6-
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months follow-up were equally distributed across both comorbid and panic disorder
only groups. In addition, patients in the comorbid group evidenced a significant reduction
in depressive symptoms at the end of the treatment. These results suggest that, for
patients with comorbid panic disorder and major depression, CBT for panic disorder may
effectively reduce both panic and depressive symptoms, even though it does not
specifically focus on the treatment of depression.
In another study, Brown, Antony, and Barlow (1995) explored the comparative
effectiveness of CBT for panic in individuals with and without comorbid psychological
disorders. Participants were 126 patients diagnosed with panic disorder and 64 patients
who had at least one additional diagnosis. Of those 64 patients, 16 had a comorbid MDD
or dysthymia diagnosis. The treatment consisted of 11 sessions of CBT for panic disorder
spread over 12 weeks. Effectiveness of treatment was evaluated by looking at the
frequency of panic attacks and the proportion of patients who were defined as functioning
at a high end-state. High end-state functioning was defined as (a) an Anxiety Disorders
Interview Schedule-Revised (ADIS-R; Di Nardo & Barlow, 1988) clinical severity rating
less than 3, and (b) a report of no panic attacks experienced within the past month.
Results indicated that the presence of comorbid depression was associated with
differential outcomes at the end of treatment. Specifically, significantly fewer (11.1%)
patients with comorbid panic disorder and depression met high end-state functioning
criteria at post-treatment than those without comorbid depression (42.9%). In addition,
when panic free status was considered in a separate analysis, significantly fewer (22.2%)
patients with comorbid depression were panic free, compared to 65.7% of patients with
panic disorder only. However, at 3-months follow-up, the differences between these
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groups were no longer significant in that 33.3% of comorbid patients and 43.5% of
panic disorder only patients met high end-state functioning criteria, and 55.6% of patients
with comorbid panic and depression and 68.1% of patients with panic disorder only were
panic free. With regard to the depressive symptoms in the comorbid group, although a
decline in depressive symptoms was evident at the end of treatment and at 3-months
follow-up, the magnitude of reduction did not reach significance. Moreover, when
comorbid patients were assessed at the 24-months follow-up, their depressive symptoms
returned to the pretreatment level. These results suggest that the presence of comorbid
depression does not significantly affect the outcome of CBT for panic disorder. However,
contrary to the results from Laberge et al. (1993) study, treatment of panic in patients
with comorbid disorders did not result in a reduction in depressive symptoms.
Another attempt to examine whether a comorbid major depressive disorder affects
the outcome of CBT for panic disorder was carried out by McLean, Woody, Taylor, and
Koch (1998). Ninety patients participated in the study. Of these, 53 were diagnosed with
panic disorder only and 37 were diagnosed with both panic disorder and major depressive
disorder. The treatment consisted of ten 60-90-minutes sessions of CBT for panic
disorder. A separate group of patients diagnosed with major depressive disorder only was
placed on a minimal therapist contact waiting list. The results indicated that, in regard to
rates of improvement, there were no significant differences between the two groups at the
end of treatment. Fifty two percent of comorbid group and 61% of panic disorder only
group achieved high end-state functioning, as defined in the Brown et al. (1995) study.
With regard to depressive symptoms in the comorbid group, no significant improvement
was evident when compared to a group of patients with major depression who were on
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the waitlist. These results again suggest that comorbid depressive disorders do not
interfere with CBT for panic disorder. In addition, the results again suggest that CBT for
panic disorder does not result in the reduction of depressive symptoms in patients with
comorbid conditions.
While the studies described previously examined the impact of the treatment for
panic disorder on major depression, Frank et al. (2000) investigated the impact of
comorbid panic symptoms on psychological treatment of depression. Participants in the
study were 61 female patients diagnosed with recurrent major depressive disorder. For
the purpose of the study, a panic-agoraphobic spectrum symptom threshold defined as a
score of 35 and above on Panic-Agoraphobic Spectrum Self-Report (PAS-SR; Cassano et
al., 1997), was developed to differentiate between clinically significant and non-
significant panic symptoms. Of 61 patients, 23 were categorized as scoring high (e.g., 35
and above) on the PAS-SR, and 38 as scoring low (e.g., 34 and lower). Patients were
treated with interpersonal therapy (IPT) for 12-24 weeks until remission was achieved or
determination of treatment non-response was made. For those patients who did not
respond to IPT treatment alone, an SSRI fluoxetine was added to the treatment regimen.
The results indicated that significantly fewer patients with high PAS-SR scores (43.5%)
responded to IPT alone compared to patients with low PAS-SR scores (68.4%). In
addition, when paroxetine was added for those patients who did not respond to IPT alone,
patients with high PAS-SR scores took longer (18.1 vs. 10.3 weeks) to respond to this
sequential treatment. These results suggest that presence of panic-agoraphobic spectrum
symptoms appears to negatively affect the outcome of IPT for depression.
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To summarize, no specific treatments for comorbid panic disorder and major
depressive disorder have been developed. Instead, research to date has focused on the
impact that the comorbid disorder may have on the treatment of the other disorder.
Preliminary evidence seems to suggest that when patients with panic disorder and
comorbid major depressive disorder are treated with CBT for panic, depressive
symptomatology does not negatively influence the outcome of panic disorder treatment.
However, CBT for panic does not appear to result in significant improvement in
depressive symptoms for patients with comorbid conditions.
In contrast, when patents with comorbid major depressive disorder and panic-
agoraphobic symptoms are treated with interpersonal therapy for depression, the presence
of panic symptoms seems to interfere with treatment of depression and to decrease the
likelihood of successful outcome. However, this conclusion is based on only one study,
and further research is needed before more definitive conclusions can be drawn.
Pharmacological Treatment of Comorbid Panic Disorder and Major Depressive
Disorder
Pharmacological treatment of comorbid panic disorder and major depressive
disorder is similar to that of either disorder in its uncomplicated form. It involves
primarily monotherapy with antidepressant agents such as monoamine oxidase inhibitors
(MAO-Is), tricyclic antidepressants (TCAs) and selective serotonine reuptake inhibitors
(SSRIs) (Johnson & Lydiard, 1998). Although MAO-Is and TCAs have been proven to
be effective in the treatment of panic disorder and major depressive disorder, they are not
widely used because of their adverse side effects. As a result, they tend to be reserved for
patients who fail to respond to, or tolerate, other antidepressants. At the present time,
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SSRIs have become the most common first-line treatment for panic disorder with
concurrent major depression, due to their documented efficacy in reducing the symptoms
associated with both conditions and the fact that they typically result in patients
experiencing less severe side-effects (Johnson & Lydiard, 1998).
With all classes of antidepressants, it may take several weeks before the
antidepressants start to have an effect on panic and depressive symptoms. Therefore, an
addition of a benzodiazepine may be helpful as an adjunct to antidepressant medications,
as it provides immediate relief of panic attacks before antidepressant therapy starts to
take an effect (Johnson & Lydiard, 1998). In addition, SSRIs and TCAs may be
associated with an increase in anxiety and panic attacks early in the course of treatment,
and the addition of a benzodiazepine can reduce any antidepressant-related anxiety
symptoms during the first few weeks of therapy (Johnson & Lydiard, 1998).
Only a very few studies have been conducted to explore the impact of
comorbidity on the effectiveness of pharmacological treatment for panic disorders and
major depressive disorders. One such study was conducted by Albus and Scheibe (1993),
who investigated the efficacy of tricyclic antidepressants imipramine and doxepine.
Participants in the study were 32 patients with panic disorder only and 20 patients with
panic disorder and comorbid major depression. Results indicated that, after 6 to 8 months
of treatment, significantly more patients with only panic disorder recovered (75%) after 6
to 8 months of treatment, compared to those with comorbid panic disorder and major
depressive disorder (35%). These results suggest that TCAs may be less effective in the
treatment of panic disorder when a comorbid major depressive disorder is present.
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Another study investigated the relative efficacy of a MAOI (moclobemide) and a
SSRI (paroxetine) in the treatment ofcomorbid depression and anxiety disorders (Pini et
al., 2003). In this study, 123 patients diagnosed with major depression and concurrent
panic disorder, generalized anxiety disorder, or other anxiety disorder were randomly
assigned to either moclobemide or paroxetine treatment lasting 4 months. Results
indicated that both medications significantly reduced depressive and anxious symptoms
for all patients. However, in the group of patients with depression and comorbid panic
disorder, patients treated with paroxetine evidenced significantly greater improvement of
depressive and panic symptoms compared to patients treated with moclobemide. In
addition, patients treated with paroxetine evidenced improvement earlier in treatment
than patients treated with moclobemide. These results suggest that paroxetine may be
more effective than moclobemide in the treatment of comorbid depression and panic
disorder.
In summary, the paucity of research data makes it difficult to draw any definite
conclusions regarding the implications of comorbidity on pharmacological treatment of
panic disorder and major depressive disorder. Available data suggest that the presence of
comorbid depression appears to complicate treatment of panic disorder in patients treated
with a tricyclic antidepressant. SSRIs and MAO-Is seem to be effective for both panic
and depressive symptoms. However, MAO-Is appear to be less effective than SSRIs.
Summary
Growing evidence suggests that patients with comorbid panic disorder and major
depressive disorder may have a more complicated nature and course of illness than
patients with either disorder alone. It has been shown that such patients experience
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greater severity of both panic and depressive symptoms, and may have poorer treatment
outcomes.
In the absence of specific psychological treatments for comorbid disorders,
research to date has focused on the impact that the comorbid disorder may have on the
treatment of the other disorder. Although limited, available research data suggests that the
presence of depression does not negatively affect the outcome of CBT for panic disorder.
At the same time, CBT for panic disorder does not appear to reduce symptoms of
depression. However, panic symptomatology appears to negatively affect the outcome of
interpersonal therapy for depression.
With regard to pharmacological treatment of comorbid panic disorder and major
depression, limited research data suggests that the presence of comorbid depression may
complicate treatment of panic disorder in patients treated with a TCA. In addition, SSRIs
and MAO-Is seem to be effective for both panic and depressive symptoms. However,
SSRIs appear to be more effective than MAO-Is.
Comorbid Panic Disorder, Major Depressive Disorder, and Alcohol Dependence
Research has documented that anxiety and depressive disorders are the most
common comorbid problems in people with alcohol abuse and dependence (Mueser &
Kavanagh, 2001). According to the Epidemiologic Catchment Area (ECA) study, among
people with an alcohol disorder, 19% have an anxiety disorder and 13% have an affective
disorder. Conversely, the rates of comorbid alcohol abuse are 30% for people diagnosed
with affective disorders and 17% for people with anxiety disorders (Reiger et al., 1990).
Despite the high comorbidity rates, little research has been conducted to address
the implications of comorbidity on management of co-occurring anxiety disorders, major
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depressive disorders, or alcohol use disorders. The majority of this research has focused
on the treatment of comorbid depression and alcohol dependence. This reviewer was not
able to identify any controlled outcome studies of psychological or pharmacological
treatment for comorbid panic disorder and alcohol dependence. Similarly, no studies
were identified that related to the treatment of clients where the presence of all three
disorders was indicated.
In the following section, available research literature regarding psychological and
pharmacological treatments for individuals diagnosed with a comorbid major depressive
disorder and alcohol dependence is reviewed, and a summary of the literature is provided.
Psychological Treatment of Comorbid Major Depressive Disorder and Alcohol
Dependence
Only a very few studies examining the psychological treatment of comorbid
major depressive disorder and alcohol dependence have been conducted. One such study
was conducted by Turner & Wehl (1984), who reviewed three studies of cognitive-
behavioral therapy (CBT) for major depressive disorder in alcohol dependent inpatients.
Each of these studies investigated the effectiveness of CBT for major depressive disorder
in patients undergoing standard inpatient treatment for alcohol problems. In the first
study, Turner, Wehl, Cannon, & Craig (as cited in Turner &.Wehl, 1984) investigated the
effectiveness of CBT in 30 alcohol dependent inpatients diagnosed with major depressive
disorder. In addition to standard inpatient treatment for alcohol dependence, participants
were randomly assigned to individual treatment with behavioral therapy (BT), cognitive
therapy (CT), or a non-directive (control) therapy. All treatment conditions consisted of 6
sessions spread over a period of 5-6 weeks. Results indicated that behavioral therapy was
71
superior to cognitive and non-directive therapy in reducing depressive symptoms. In
addition, a significantly greater number of patients achieved remission (defined as BDI
score of 10 or less) in both BT and CT groups than in non-directive therapy group.
In the second study, Wehl, Turner, Cannon, & Craig (as cited in Turner & Wehl,
1984) compared the relative efficacy of 6 sessions of group versus individual CBT in a
sample of 64 alcohol dependent inpatients diagnosed with major depressive disorder. The
participants were randomly assigned to CBT for depression conducted in an individual or
group format, or standard inpatient treatment. The last condition did not receive specific
treatment for depression and served as a control group. Results indicated that individual
CBT was superior to standard inpatient treatment in reducing depressive symptoms. In
addition, a significantly greater proportion (75%) of patients in the individual CBT
condition achieved remission, compared to standard inpatient treatment, where 38% of
patents achieved remission. Although patients in group CBT condition evidenced greater
improvement in depressive symptoms than controls, the difference was not significant.
In the third study, Turner, Wehl, and Moreno (as cited in Turner & Wehl, 1984)
analyzed the results of data collected during a follow-up of the patients previously
described in the study by Wehl and colleagues. During a 1-year follow-up, data regarding
drinking status were gathered every month. Results indicated that patients treated with
individual CBT for depression drank less frequently. In addition, they less frequently
drank to the point of intoxication when they did drink.
Similarly to the studies reviewed above, Brown, Evans, Miller, Burgess, and
Mueller (1997) examined whether the addition of CBT to standard alcohol treatment
would result in reduced levels of depressive symptoms and in reduced quantity and
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frequency of alcohol use. In this study, 35 patients who were diagnosed with alcohol
dependence and who had a BDI score of 10 or greater were assigned to one of two
groups. The first group received treatment with CBT, whereas the second group received
relaxation training (RTC) and served as a control group. Both treatment conditions lasted
8 weeks and were provided in addition to standard alcohol treatment. Random
assignment was not used in this study because of concerns about the possibility of
treatment contamination should participants compare treatment manuals and procedures.
Instead, patients were treated in sequential non-overlapping cohorts with a washout
period between cohorts so that only one treatment condition was conducted at a given
time.
Results indicated that patients treated with CBT experienced a significantly
greater reduction in depressive symptoms compared to patients treated with RTC at the
end of treatment. With regard to drinking, at 6-months follow-up, a significantly greater
number (47%) of patients treated with CBT were abstinent than those in the RTC
condition (13%). Of those who continued drinking during the follow-up period, patients
in the CBT condition were abstinent on significantly more days (90%) than patients
treated with RTC (68% of abstinent days). In addition, on those days when they drank,
CBT patients consumed significantly fewer drinks per day (0.46 vs. 5.71) than RTC
patients.
Taken together these studies suggest a number of conclusions. First, the results of
these studies suggest that comorbid alcohol dependence does not appear to interfere with
CBT for depression. Second, available research evidence suggests that CBT of
depression in alcohol dependent patients may effectively reduce depressive symptoms.
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Finally, treating major depressive disorder comorbid with alcohol dependence with CBT
for depression appears to reduce drinking behaviors as well. Despite these encouraging
initial conclusions, it should be noted that they are made on a basis of a limited number of
studies using small sample sizes. Thus, drawing of definitive conclusions is difficult. As a
result, additional research must be conducted before more definitive conclusions can be
made.
Pharmacological Treatment of Comorbid Major Depressive Disorder and Alcohol
Dependence
With regard to pharmacological treatment of depression in alcohol dependent
patients, limited evidence suggests that antidepressants may effectively reduce depressive
symptoms in individuals diagnosed with major depressive and alcohol dependence
disorders. For example, Mason, Kocsis, Ritvo, and Cutler (1996) attempted to determine
the effectiveness of a tricyclic antidepressant desipramine in reducing both depressive
symptoms and alcohol consumption in patients diagnosed with alcohol dependence.
Participants in the study were 71 patients diagnosed with alcohol dependence. Of these
patients, 28 were also diagnosed with secondary major depressive disorder, (i.e., with
onset following the onset of alcoholism). Patients were randomly assigned to 6-months of
double-blind treatment with either desipramine or placebo. Equal proportions of patients
with comorbid major depressive disorder were present in each treatment condition.
Results indicated that significantly more patients with comorbid major depressive
disorder and alcohol dependence (82%) achieved a significant decrease in depressive
symptoms compared to such patients in the placebo group (22%) at the end of treatment.
With regard to drinking outcomes, patients in desipramine group remained abstinent
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significantly longer (167 days) than patients receiving placebo (117 days) during the 6
months of the study. This was true for patients diagnosed with alcohol dependence only
and for patients diagnosed with alcohol dependence and comorbid major depressive
disorder. However, when results of the depressed subgroup were analyzed separately, a
different pattern of results emerged. There were no significant differences between the
number of days abstinent in patients treated with desipramine (109 abstinent days) and
placebo (65 abstinent days). Similarly, there were no significant differences in relapse
rates between depressed patients treated with desipramine (8.3% of relapsed patients) and
placebo (40% of relapsed patients). In the non-depressed group, relapse rates in patients
treated with desipramine (14.3%) did not differ significantly from those of placebo
patients (26.7%). These results suggest that desipramine may effectively reduce
symptoms of secondary depression in patients with alcohol dependence. In addition,
using desipramine to treat depression secondary to alcohol dependence may reduce risk
for drinking relapse in some depressed patients but not in non-depressed patients.
Another study (McGrath et al., 1996) investigated the effectiveness of a TCA
imipramine in reducing depressive and alcohol dependence symptoms in 69 patients
diagnosed with comorbid major depressive disorder and alcohol dependence. In this
study, major depressive disorder was primary (i.e., with onset prior to onset of
alcoholism). Participants were randomly assigned to a 12-weeks treatment with either
imipramine or placebo. Results indicated that imipramine was significantly more
effective than placebo in reducing depressive symptoms. With regard to drinking
outcomes, patients treated with imipramine evidenced a non-significant decrease in the
number of drinking days and in .the number of drinks per drinking day. These results
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suggest that imipramine may effectively reduce symptoms of primary major depressive
disorder in patients with alcohol dependence, but it may not have a significant impact on
drinking behaviors.
Studies reviewed above investigated the effectiveness of TCAs in the treatment of
comorbid major depressive disorder and alcohol dependence. Cornelius et al. (1997)
attempted to examine the effectiveness of an SSRI (fluoxetine) in the treatment of these
comorbid conditions. Participants were 51 patients diagnosed with major depressive
disorder and alcohol dependence. Participants were randomly assigned to 12-weeks of
double-blind treatment with either fluoxetine or placebo. Results indicated that the
improvement in depressive symptoms was significantly greater in the fluoxetine group
than in the placebo group at the end of treatment. In addition, compared to patients
treated with placebo, patients treated with fluoxetine drank three times less alcohol
during 12-weeks treatment, had two times fewer drinking days, two times fewer drinks
per drinking day, and three times fewer days of heavy drinking (defined as 5 or more
drinks per day). Moreover, patients treated with fluoxetine remained abstinent twice as
long as those in the placebo group. These results suggest that fluoxetine may be effective
in reducing both depressive symptoms and symptoms of alcohol dependence for patients
with comorbid major depressive and alcohol dependence disorders.
In summary, the limited number of studies makes it difficult to draw definitive
conclusions regarding the effectiveness of pharmacological treatments for comorbid
major depressive and alcohol dependence disorders. Some evidence indicates that TCAs
and SSRIs may effectively reduce depressive symptoms in patients with alcohol
dependence. However, the limited evidence available suggests that only the SSRIs may
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be effective at improving both the symptoms of depressive and alcohol dependence
disorders.
Summary
Despite high comorbidity of panic, major depressive, and alcohol use disorders,
limited research evidence exists regarding the effective treatment of clients with
comorbid conditions. The evidence that is available has focused solely on the treatment
of comorbid major depressive disorder and alcohol dependence. Limited evidence
suggests that cognitive-behavioral therapy may be effective in improving depressive
symptoms in patients with comorbid major depressive disorder and alcoholism. In
addition, some evidence suggests that CBT for depression may improve drinking
behaviors in these patients.
With regard to pharmacological treatment of comorbid major depressive disorder
and alcohol dependence, limited evidence indicates that SSRIs may be effective in
reducing both depressive symptoms and drinking behaviors. TCAs also may effectively
improve depressive symptomatology in patients with comorbid major depressive and
alcohol dependence disorders. However, evidence regarding the effectiveness of TCAs in
reducing alcohol consumption for these patients is inconclusive at best.
In summary, future research must be conducted to provide more data regarding
psychological and pharmacological treatment of patients with comorbid major depressive
disorder and alcohol dependence.
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Chapter 3
Normative Practice and Outcomes
The agency
Ms. Williams' treatment took place at a community mental health center. The
agency is a non-profit agency that provides an array of behavioral health and human
services across several treatment programs, including outpatient services, adult partial
care, MICA partial care, and residential programs. The primary population the agency
serves includes clients discharged from state, county or local psychiatric hospitals, those
referred from crisis centers, clients with a history of repeated psychiatric hospitalizations,
and chronically mentally ill clients. Among these categories of clients, the agency gives
priority to mentally ill children and elderly clients, minorities, clients with Medicaid or
Medicare, and those who do not have any medical insurance.
The agency receives funding from the New Jersey Department of Human
Services, Division of Mental Health Services. It operates on a sliding fee scale and limits
its services to Camden County residents.
Ms. Williams' intake session was scheduled four days after she contacted the
agency. Following the intake, Ms. Williams was accepted into the outpatient services
program. The program offers services such as individual, group, and family therapy,
psychiatric evaluation and medication monitoring, and assessment and referral. Due to
high volume of clients and large caseloads, therapists in the outpatient program typically
see clients every two to four weeks. However, as a graduate student, Ms. Williams'
therapist had a limited caseload that allowed her to see Ms. Williams every week. Two
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days after the intake, Ms. Williams underwent a psychiatric evaluation performed by a
psychiatrist in the agency, and she was prescribed Paxil, a selective serotonin reuptake
inhibitor with antidepressant and anxiolytic properties. The initial dose was 25mg a day.
Although Ms. Williams emphasized her need for individual therapy during intake,
she did not begin therapy until three weeks later, reportedly due to financial difficulties.
In the first therapy session, the possibility that Ms. Williams may receive a new therapist
in the near future was discussed. She was informed that the therapist would leave the
agency in approximately four months due to the end of the internship term. Ms. Williams
agreed to work with this therapist for the time being and to transfer to another therapist in
the agency to continue her individual treatment after this therapist left. Ms. Williams also
consented to participate in this single-subject study and to have her therapy sessions
audio taped.
Over the 17-weeks of treatment, Ms. Williams attended 14 individual therapy
sessions with this therapist and 5 medication-monitoring sessions with agency's
psychiatrist. Three individual therapy sessions were missed during the course of
treatment. One missed session was due to a death in Ms. Williams's family, and the two
other missed sessions were due to her drinking binges.
Treatment planning
In developing a treatment plan for Ms. Williams, several factors were considered.
First, Ms. Williams's problems were conceptualized in cognitive-behavioral terms;
therefore, planning began with the premise that cognitive-behavioral therapy would be
the treatment of choice for her. In addition, the choice of cognitive-behavioral therapy as
a preferred treatment was supported by the extensive empirical evidence of effectiveness
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of cognitive-behavioral strategies in the treatment of panic disorder, major depression
and alcohol dependence. The specific techniques utilized in Ms. Williams's treatment
will be discussed in subsequent sections. In addition to cognitive-behavioral techniques,
psychoeducational strategies were thought to play a significant role in the treatment
process, because they are an integral part of the cognitive-behavioral approach.
Second, Ms. Williams' symptoms were conceptualized as stemming from both a
lack of adequate coping skills to deal with a stressful life situation she experienced and
negative beliefs that were thought to underlie her symptoms. Therefore, there seemed to
be three broad treatment goals: (1) reducing her of symptoms of distress (2) decreasing
her emotional suffering and (3) identification and modification of long-standing patterns
of thinking and behavior that prevent long-lasting resolution of symptoms.
Third, Ms. Williams reported having great difficulty dealing with the break-up
with her fianc6. Apparently, she experienced strong feelings of loss and grief associated
with this event, and these feelings might have contributed to her current symptoms.
Therefore, the exploration and resolution of grief over the lost relationship needed to be
incorporated into Ms. Williams' treatment.
With regard to other aspects of treatment planning, the importance of a strong
therapeutic alliance and a safe and trusting client-therapist relationship could not be
overlooked, as it is strongly emphasized in the application of any approach to
psychological treatment. To establish a working therapeutic relationship, intervention
strategies such as empathy, active listening, communication of respect and acceptance
would be utilized. Finally, some psychodynamic intervention strategies, such as
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interpretation, confrontation, and other techniques were to be used during treatment
implementation to aid in the exploration of issues relevant to treatment.
With regard to the timing of sessions and duration of treatment, it was thought
that Ms. Williams would benefit from 50-55-minutes sessions of individual therapy once
a week. The medication monitoring sessions with a psychiatrist usually lasted 15 minutes,
and it would be scheduled every four weeks. Consisted with the agency's policy, the
treatment plan was developed for a period of six months. If Ms. Williams did not achieve
adequate symptom reduction, new treatment plan for a period of another six month would
be developed and implemented. Given the severity and complexity of Ms. Williams'
current symptoms and the need to work on changing her negative beliefs preventing a
long-term resolution of the symptoms, the duration of her treatment was anticipated to be
at least six months. The new treatment plan would be developed after this initial
treatment period.
The treatment plan
I. Treatment goals and objectives.
1. The client will report a reduced number of panic attacks.
a) The client will keep self-monitoring records documenting the frequency of
panic attacks, levels of anxiety and depression, and the amount of fear related
to panic attacks.
b) The client will be educated about the role of negative cognitions, catastrophic
imagery, and misinterpreted physical sensations in the development of panic
attacks.
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c) The client will learn and practice progressive muscle relaxation to manage
her anxiety symptoms.
d) The client will learn and practice cognitive restructuring related to
catastrophic misinterpretation of panic symptoms.
e) The client will explore, identify, and modify negative beliefs maintaining her
anxiety symptoms.
2. The client will report a reduction in depressive symptoms.
a) The client will be educated about the role of negative cognitions in the
development and maintenance of depressive symptoms.
b) The client will learn and practice identifying and modifying negative
cognitions leading to depression and hopelessness.
c) The client will identify self-defeating behaviors maintaining her depressive
symptoms and identify and engage in more self-rewarding behaviors.
d) The client will enter the Women's Support Group in the agency to develop a
better social support network.
e) The client will explore, identify, and modify automatic thoughts and core
beliefs maintaining her depressive symptoms.
3. The client will report a reduction in alcohol use.
a) The client will identify intrapersonal and interpersonal cues precipitating her
drinking.
b) The client will identify and practice alternative ways to cope with
intrapersonal and interpersonal stressors leading to the alcohol use.
c) The client will attend Alcoholics Anonymous meetings at least once a week.
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d) The client will develop a network of Alcoholics Anonymous sponsors to
create a social support network for herself.
4. The client will report a reduction in the level of distress and emotional suffering
associated with the loss of her relationship with her fianc6.
a) The client will explore her feelings regarding the break-up with.her fiance and
how these feelings might contribute to anxiety, depression, and alcohol use
she is experiencing.
b) The client will identify and modify cognitions and behaviors maintaining her
feelings of rejection and hopelessness associated with the break-up.
5. The client will comply with the medication regimen.
a) The therapist will educate the client about the importance of medication
compliance and provide the client with the information about medication.
b) The client will attend medication-monitoring sessions with Dr. Jones, MD3
every four weeks and report on the effectiveness of the medication in reducing
symptomology, and on the side effects of the medication.
II. Interventions: Primarily cognitive-behavioral, with a focus on the therapeutic
relationship. In addition, some psychodynamic therapy elements will also be
incorporated.
III. Timing of sessions: 50-55 minutes sessions of individual therapy, once a week; 15-
minutes sessions of medication monitoring every four weeks.
IV. Duration of treatment: 6 months.
3 The name is fictional to protect the client's confidentiality
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Assessment ofprogress and outcome
Assessment of Ms. Williams' progress in treatment was achieved using several
measures.
Outcome Questionnaire - 45.2 (OQ-45.2; Lambert, Hansen, et al., 1996). The
OQ-45.2 was completed by Ms. Williams at the beginning of each session. The OQ-45.2
is a brief 45-item self-report instrument designed for repeated measurement of the client's
progress throughout the course of therapy. The OQ-45.2 takes, on average, 5-7 minutes to
complete. Clients are asked to rate how often they experience a variety of behaviors and
symptoms on a 5-point Likert scale ranging from "not at all" (0) to "almost always" (4).
The OQ-45.2 measures client's functioning in three domains that correspond to
three subscales. The first subscale, Symptom Distress (SD), emphasizes anxiety,
depression, and substance abuse symptoms. The second subscale, Interpersonal Relations
(IR), represents problems with relationships, family life, marriage; and elements of
isolation, feelings of inadequacy, withdrawal, or conflict. The third subscale, Social Role
Performance (SR), gauges client's level of dissatisfaction, conflict, or distress in their
employment, family roles, and leisure life. In addition, the OQ-45.2 contains risk
assessment items for suicide potential and potential violence at work.
The OQ-45.2 yields four scores: the Total Score representing generalized distress
and the three subscale scores (SD, IR, and SR). Greater scores represent greater distress.
Each score obtained by the client is compared against a cut-off score to see if the client's
score falls in the "dysfunctional" range. In addition, data on the OQ-45.2 has indicated
various Reliable Change Indices (RCI) that represent a size of the difference needed to
achieve a clinically significant change for all four scores. The score ranges, cut-off scores
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and Reliable Change Indexes (RCI) for Total Score and SD, IR, and SR subscales are as
follows:
Total Score: range = 0 -180; cut-off= 63; RCI = 14.
Symptom Distress (SD): range = 0 - 100; cut-off= 36, RCI = 10.
Interpersonal Relations (SR): range = 0 = 44; cut-off= 15; RCI = 8.
Social Role (SR): range = 0 - 36; cut-off = 12; RCI = 7.
With regard to the psychometric properties of the OQ-45.2, this measure has high
reliability. Internal consistency coefficients have been reported to range from .70 to .93
(Lambert, Burlingame, et al., 1996). Test-retest reliability coefficients have been reported
to range from.78 to .84 over a 3-weeks period (Lambert, Burlingame, et al., 1996).
With regard to validity, concurrent validity of the OQ-45.2 has been reported to
be high for the Total Score and for the Symptom distress subscale (Umpress, Lambert, &
Smart, 1997). The correlations between the OQ-45.2 and the Global Severity Index of the
Symptom Checklist-90 (SCL-90; Derogatis, 1983) ranged from .78 to .88 for the Total
Score and from .82 to .92 for the Symptom Distress score. The concurrent validity of the
Interpersonal Relations and Social Role subscales has been reported to be moderate to
high. The correlations between the Interpersonal Relations and Social Role subscales of
the OQ-45.2 and the Inventory of Interpersonal Problems (IIP; Horowitz, Rosenberg,
Baer, Ureno, & Villesenor, 1988) have been reported to range from .49 to .64.
CAS - Combined Alliance Scale (CAS; Hatcher & Barrends, 1996) is a brief 33-
items questionnaire designed to assess the quality of the therapeutic relationship. Items
are rated on a 7-point Likert scale ranging from "not at all" (1) to "very much" (7). The
CAS takes, on average, 5-7 minutes to complete. The CAS has five subscales. The first
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subscale, Confident Collaboration, represents the client's confidence that the therapy is
working. The second subscale, Goal and Task Agreement, reflect the degree to which the
client and the therapist agree on what should be the focus of treatment. Items on the third
subscale, Bond, measure the degree to which the client perceives the therapist as caring
about him/her. The fourth subscale, Idealized Relationship, measures the degree to which
clients disagree with the therapist and believe that the therapist is not helpful. The last
subscale, Dedicated Patient, represents the degree to which the client is willing to be open
and forthcoming in the treatment, despite feelings of frustration and worries about the
progress and outcome of treatment.
CAS subscale scores are expressed as percentiles that are used for interpretation,
with the greater percentiles representing greater therapeutic alliance and better
therapeutic relationship quality.
The CAS has adequate reliability. The internal consistency coefficients for five
subscales have been reported to range from .40 to .78 (Hatcher & Barrends, 1996).
Concurrent validity of the CAS has been reported to be adequate to good. The
correlations between the CAS and the Working Alliance Inventory (WAI; Horvath &
Greenberg, 1989), the California Psychotherapy Alliance Scales (CALPAS; Gaston,
1991), and the Penn Helping Alliance Questionnaire (HAQ; Alexander & Luborsky,
1986) averaged .59, .55, and .54, respectively.
Due to the therapist mistake, the CAS was not given to Ms. Williams until the
11th session into treatment. To gather data about how Ms. Williams perceived the
therapeutic relationship throughout treatment, the scale was modified, and Ms. Williams
was asked to rate each item three times. For each item, she first retrospectively estimated
86
the highest rating, then the lowest rating, and then she rated her current experience in
therapy for that item.
Informal assessment of the therapeutic alliance was done two times throughout
the treatment by asking Ms. Williams what was the worst thing in today's session and
what she would like to change in how the treatment is going.
Panic Attack Record (Barlow & Cemy, 1988). Beginning with the third therapy
session, Ms. Williams was instructed to fill out the panic attack record every time she had
a panic attack and bring the records to each session. The panic attack record was adopted
from the panic disorder treatment manual. For each panic attack, Ms. Williams recorded
it's time of onset, duration, maximum intensity, physical sensations she was
experiencing, and whether the attack was expected or not. In addition, Ms. Williams was
asked to record a brief description of the situation in which the panic attack occurred, any
thoughts that occurred just prior to or during the attack, and the perceived cause of the
attack (see Appendix B).
Weekly Record of Anxiety and Depression (Barlow & Cerny, 1988) was
introduced in the third therapy session. Ms. Williams was instructed to fill out the weekly
record of anxiety and depression every night before bedtime and bring the record to every
session. For each day of the week, using the scale from 0 ("none") to 8 ("as much as you
can imagine"), she recorded average levels of anxiety, depression, pleasantness, and fear
of a panic attack throughout the day. In addition, she recorded the maximum level of
anxiety she experienced that day, and the dosages and amounts of the medication she




During intake session, only basic information about Ms. Williams' presenting
problems and background information was obtained. To more clearly understand the
client, the first three individual therapy sessions with Ms. Williams were devoted to
learning more details about her symptoms and psychosocial history, establishing rapport
between Ms. Williams and the therapist, and gathering baseline data. In the second
session, the Outcome Questionnaire-45.2 was introduced and informed consent for
participation in the study was obtained. In addition, Ms. Williams consented to having
her sessions audio taped. In the third session, the therapist introduced the self-recording
forms for documenting panic attacks (Panic Attack Record), and daily levels of anxiety,
depression, and fear of panic attacks (Weekly Record of Anxiety and Depression). Ms.
Williams was instructed to begin using the forms and to bring them with her to each
session.
Because Ms. Williams was diagnosed with three disorders, it was necessary to
prioritize on which problem she wanted to work first. Ms. Williams stated that panic
disorder symptoms caused her the greatest distress. She also reported that besides panic
attacks, she had the most difficult time dealing with the end of her relationship with her
fianc6. Her depression was precipitated by this event, and it was thought that working
with thoughts and feelings associated with the break-up would help decrease depressive
symptoms. Finally, Ms. Williams stated that alcohol dependence problems were of the
least concern for her at the present time. She reported that since she started taking
medication and coming to therapy, she was able to abstain from alcohol.
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Ms. Williams canceled one session during the assessment period because her
cousin's husband died and she was helping her cousin with the funeral.
Treatment
In the fourth session, the therapist introduced cognitive-behavioral therapy for
panic disorder and major depressive disorder. The theoretical foundations of cognitive-
behavioral therapy were explained, and examples from Ms. Williams' life were discussed
to illustrate the major concepts. Since the primary goal of treatment was to decrease panic
disorder symptoms, panic attacks were explained to Ms. Williams in cognitive-behavioral
terms and cognitive-behavioral methods for treatment of panic disorder were presented.
In addition, the importance of homework and the client's active participation in the
treatment was emphasized. The therapist also provided Ms. Williams with a hand-out that
contained information on the nature and causes of panic disorder and cognitive-
behavioral treatment for panic disorder. (Leahy & Holland, 2000).
In the following sessions, the therapist introduced progressive muscle relaxation
as a method for reducing anxiety. The relaxation exercises consisted of tensing and
relaxing 16 different groups of muscles. In the following session, relaxation with
discrimination training for the 16 muscle groups was introduced. During this phase of
training, Ms. Williams was asked to tense her muscles only half as much as usual in order
to learn to discriminate between high and low levels of muscle tension. In later sessions,
the discrimination training procedure was shortened to eight and then to four muscle
groups. For each relaxation exercise, Ms. Williams was instructed to practice relaxation
twice a day at home and to fill out the Relaxation Practice Record every time she
practiced. The Relaxation Practice Record was adopted from the Barlow and Cerny's
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(1988) manual. For each relaxation practice, Ms. Williams was asked to note the date
and time of the practice and her anxiety level before and after practice. Using a scale
from -10 ("extreme increase in tension") to +10 ("extreme increase in relaxation"), she
was asked to note the degree to which she was able to relax. Finally, she was to briefly
describe her experiences during the relaxation, including any thoughts, feelings, or
problems (see Appendix B). Ms. Williams was instructed to bring the Relaxation Practice
Record to every session in order to discuss any problems that might have occurred during
the practice.
Ms. Williams was enthusiastic about the relaxation exercises, practiced them at
home, and reported that her anxiety had decreased somewhat since she started the
relaxation practice. However, she reported that when tensing muscles, she experienced
muscle pain caused by fibromialsia. To deal with this problem, Ms. Williams was advised
to skip the tension part of the exercise and do only the relaxation part.
According to Barlow and Cerny (1988), after the relaxation is introduced and
practiced, in the next session the therapist should introduce techniques for monitoring
cognitions. The authors also suggest that the client has to be taught to monitor cognitions
pertaining to panic attacks, such as "I am going crazy", or "I am having a heart attack".
However, from analysis of Ms. Williams' panic attack records, it became evident that the
majority of Ms. Williams' panic attacks were precipitated by her thoughts about how she
missed her ex-fianc6, her feelings of loneliness and hopelessness, and her fear of the
future. The therapist hypothesized that working with cognitions related to these issues
would help to decrease symptoms of both panic and major depressive disorder. Instead of
focusing on cognitions specific to panic disorder, as specified in the manual, the therapist
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decided to teach Ms. Williams to identify and modify cognitions using her thoughts
related to issues such as her relationship with her fianc6, hopelessness, etc. Ms. Williams
was instructed to monitor her thoughts by asking herself "what is going through my mind
right now?" whenever she felt sad or anxious. She was asked to try to monitor her
thoughts at home and to write them down for discussion in the session. Although Ms.
Williams seemed to understand the concept of thought monitoring, she experienced
difficulties with identifying automatic thoughts. While this difficulty is normal for people
learning to monitor their cognitions and their effect on mood (Beck, 1995), the therapist's
inexperience in applying cognitive techniques made it even more difficult for Ms.
Williams to learn to identify her automatic thoughts. Therefore, instead of assigning a
thought monitoring homework, the therapist decided to work on identifying and
modifying Ms. Williams' negative thoughts in session.
In later sessions, the therapist introduced cognitive therapy techniques that were
used to examine the evidence for and against negative thoughts and to explore alternative
explanations. These techniques were used to modify negative thoughts Ms. Williams
expressed in sessions, such as "I am weak", "I will never get better", etc. After examining
evidence for and against these negative cognitions, positive statements counteracting
them were formulated, and Ms. Williams was asked to write them down and read them at
home. Ms. Williams reported that reading positive statements helped her to feel less
depressed and hopeless.
Other issues discussed in the first therapy sessions were Ms. Williams' lack of
social support and alcohol use. With regard to social support, Ms. Williams reported that
her cousin still was the only person who provided emotional support for her. However, at
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that time, her cousin had to deal with her own feelings of loss and grief over the death of
her husband, and needed emotional support herself. Thus, Ms. Williams found herself
providing support for her cousin and realized that it helped her to take her mind off her
own issues. With regard to Ms. Williams' relationship with her mother, Ms. Williams
reported that it became less strained and emotionally abusive after Ms. Williams started
therapy. Ms. Williams reported that she talked to her mother about how depressed,
hopeless, and unhappy she felt after the break-up with her fiance. Her mother was able to
empathize with Ms. Williams' feelings and expressed her willingness to support Ms.
Williams in her efforts to overcome her difficulties. However, Ms. Williams'
relationships with her brother and sister-in-law were still strained. To help Ms. Williams
develop a social support network and to have more opportunities for socializing outside
her immediate family, the therapist recommended that Ms. Williams joined the Women's
Support Group in the agency. Ms. Williams stated that she herself thought about joining
the group and would do that in the nearest future.
With regard to the alcohol use, Ms. Williams reported that she had been abstinent
since she started taking an antidepressant. Ms. Williams also reported that her cousin
continued to be the only Alcoholics Anonymous (AA) sponsor she had, and that she
attended an average of one AA meeting a week. The therapist encouraged Ms. Williams
to develop a network of AA sponsors. Other alcohol related issues were not discussed in
these sessions.
In the fifth therapy session Ms. Williams reported feeling less depressed,
attributing the change to an increased dose of Paxil. The dose had been increased to
37.5mg a day, and she had been taking this dosage for a week prior to this session.
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By the sixth session, Ms. Williams' total score on OQ-45.2 had dropped by 23
points compared to the beginning of the treatment, and it was 3 points higher than scores
in the "functional range." (see Figure 1). The decrease of 14 points on the total score
represented a clinically significant change in overall symptomatology. In addition, Ms.
Williams' scores on Symptom Distress and Interpersonal Relationships scales decreased
by 10 and 12 points respectively, also representing a clinically significant change.
However, while the score on the Interpersonal Relationships scale reached the normal
range, the Symptom Distress score was still in the dysfunctional range. Ms. Williams'
score on the third subscale, Social Relationships, was in the functional range from the
beginning of the treatment and never reached the dysfunctional score range. With regard
to the panic attacks, their number decreased from 30 per week in the 4th session to 20 per
week at session 6 (see Figure 2).
The next six weeks (7th to 10th session) proved to be a very difficult period for
Ms. Williams. While her anxiety symptoms were gradually decreasing due to continued
relaxation practice, the depressive symptoms worsened despite the initial good response
to an increased dose of Paxil. Ms. Williams described how spring brought memories of
happy times with her fianc6, and how her feelings of loneliness and grief intensified
during Easter holidays, which she had previously spent with her fianc6 and her daughter.
Ms. Williams reported that the memories of times spent with her fiance were so painful
that it was difficult for her to fill out the panic attack records. She stated that this
difficulty was related to the need to focus on these memories in order to write them
down, which would bring additional pain. At Ms. Williams' request, it was agreed that
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every session she would verbally report to the therapist the number of panic attacks per
week and their average intensity instead of filling out the panic attack records.
Unable to cope with overwhelming feelings of sadness, loneliness, and
hopelessness, Ms. Williams started drinking again. During a six-week period she missed
two scheduled therapy sessions because of drinking and reported one drinking episode
between sessions. In addition to the feelings of loneliness and grief over the lost
relationship, Ms. Williams experienced intense guilt and anger towards herself for not
being able to stay abstinent.
Cognitive techniques were used to help Ms. Williams overcome feelings of loss
and grief over the relationship with her fiance and her feelings of powerlessness over
alcohol. In addition, empathy, emotional support, and encouragement were used. The
therapist frequently communicated to Ms. Williams respect for and encouragement of,
her continued efforts to overcome her problems.
Gradually, a positive shift in Ms. Williams' mood began to occur. She began to
re-evaluate her relationship with her fiance, and her perception of the relationship as
being "perfect '" began to change to more realistic and objective one. Instead of attributing
the blame for the break-up entirely to herself, she began to see how both she and her
fianc6 were responsible for the relationship deterioration and end. With regard to alcohol
use, Ms. Williams began to attend AA meetings three times a week. However, she was
still reluctant to contact her AA sponsors when she experienced alcohol cravings, because
it was "difficult for her to ask for help". After Ms. Williams got intoxicated for the third
time in four weeks, her mother and brother insisted that she enter a 30-day inpatient
treatment for alcohol dependence. To avoid hospitalization, Ms. Williams made a
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commitment to attend 90 AA meetings in 90 days. In therapy, almost the entire session
during this time was devoted to identification of external and internal drinking cues and
to development of constructive ways to cope with them.
Other issues discussed in sessions 7 to 10 were relaxation practice, lack of self-
rewarding activities and continued lack of social support. Ms. Williams continued to do
the relaxation exercises at home and reported no problems. To help her generalize the
relaxation skill to different situations, she was instructed to practice relaxation in
different rooms in the house and at different times during the day. With regard to self-
rewarding behaviors, Ms. Williams was reluctant to engage in activities outside of home
despite the therapist's continuing encouragement to do so. She argued that all the things
she liked to do, such as gardening, walking, or fishing, she was previously doing with her
fianc6. She feared that if she was to engage in these activities alone, the memories of
times spent happily together would provoke intense sadness and panic attacks. In
addition, when Ms. Williams' cousin or other members of her family invited her to go
shopping or to attend a family gathering, she would refuse because she "did not want to
spoil their fun with her misery". Thus, the vicious cycle of avoiding activities and
experiencing a lack of self-reward perpetuated her feelings of depression and loneliness.
The struggle and increased distress Ms. Williams experienced in these six weeks
was reflected in increase of the OQ-45.2 score and the number of panic attacks. Between
seventh and tenth session, Ms. Williams' OQ-45.2 score increased by 32 points, reaching
the level higher than in the beginning of therapy (see Figure 1). In addition, the number
of panic attacks, which decreased to 6 in week 10, increased sharply and reached 20 in
week 12 (see figure 2).
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The last four therapy sessions with Ms. Williams were marked by sudden
improvement in the symptoms of panic, depression, and alcohol use. In the 11th session
Ms. Williams reported that in the previous week she did not experience any panic attacks,
she felt significantly less depressed, and did not experience alcohol cravings. The sudden
improvement in symptomatology was brought on by significant changes in Ms. Williams'
behavior. Consistent with the commitment made in the previous weeks, she attended AA
meetings daily. The emotional support she received from other AA members helped her to
feel hopeful about her struggle with alcohol. One of the men she met invited her to a
wedding reception held by his friend. Ms. Williams reported that, contrary to her previous
attitude towards going out, she decided to accept the invitation. She described a week-end
spent with the man, his grown-up children, and other AA members as "the best thing that
happened to me in the past several months." Ms. Williams reported that, contrary to her
expectations, she was able to fully enjoy the reception and felt liked and accepted by her
new acquaintances. Since that event, Ms. Williams started going out with her fellow AA
members and her family members.
While all these exciting changes were happening in her life, in therapy, the work
on the grief over the lost relationship continued. Ms. Williams gradually began to accept
the fact that her relationship with her fianc6 ended and that she had to continue her life
without him. She began to think about her future and, though she was not able to make
any plans yet, she did not feel hopeless anymore. She even started to make small steps
towards starting a new period in her life. For example, she described how, following the
therapist's recommendations, she went alone to one of the places that she often visited
with her fianc6. She reported that although she still felt that she missed him, she spent an
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enjoyable day there. Contrary to her predictions, she experienced neither panic attacks
nor depression on that day. This experience helped Ms. Williams realize that her fear of
having panic attacks at places that would bring up memories of her fiance was unjustified.
Another issue discussed in the last four sessions was Ms. Williams' developing
relationship with a man she recently met. Consistent with the AA philosophy, she was
cautious not to get involved with the man emotionally for at least a year after she achieved
abstinence from alcohol. On the other hand, she longed for intimacy and companionship.
Cognitive and psychodynamic techniques were used to explore Ms. Williams'
ambivalence about engaging in a romantic relationship and her intense fear of loneliness.
Additionally, cognitive techniques were used to uncover Ms. Williams' belief that she was
worthless and unlovable, and she expressed her willingness to work on changing these
beliefs. To start with this task, cognitive therapy techniques were used to raise Ms.
Williams' self-esteem. With the help from the therapist, Ms. Williams created positive
statements about herself. She then was instructed to write them down, place them at
prominent places at home, and read them several times a day. In addition, a self-help book
on self-esteem (McKay & Fannning, 2000) was recommended to Ms. Williams for
reading at home.
Other issues discussed in these sessions were finishing the relaxation part of the
panic disorder treatment and termination of work with this therapist. With regard to
relaxation, Ms. Williams was instructed on how to do relaxation by recall, which involves
identifying any feelings of tension in the muscles and then relaxing them by recalling how
the relaxed muscles feel. In later sessions, cue-controlled relaxation was introduced, where
the relaxation of all muscle groups was achieved by thinking the word "relax". Ms.
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Williams reported no difficulties in practicing either relaxation by recall or cue-
controlled relaxation. To generalize the cue-controlled relaxation skill, she was instructed
to practice it first in different places at home and then outside of home. She also was
instructed to use cue-controlled relaxation to release tension whenever she felt anxious
and stressed out.
The final issue discussed in the last four sessions was termination of treatment with
this therapist and transfer to another therapist in the agency. Given Ms. Williams' recent
history of loss of a significant relationship, her feelings about termination were explored
several times during concluding sessions of treatment. While reacting with apparent
distress when the issue was discussed for the first time, gradually Ms. Williams was able
to accept still another change in her world. With the help of the therapist, she developed a
summary of her experience in therapy. She was encouraged to recall all her struggles and
ups and downs, as well as accomplishments and skills learned in therapy. To ease the
transition from one therapist to another, some anticipated differences between her current
and future treatment were discussed, such as possible difference in therapists' styles and
greater spacing between sessions. In the final session with this therapist, her new
therapist's contact information along with the next appointment time was given to Ms.
Williams.
The improvement in Ms. Williams' condition was reflected in her OQ-45.2 Total
Score which remained within normal range for the last four weeks of therapy. The
Symptom Distress score, however, was still above the cut-off point, suggesting that some
work still had to be done. For the last four therapy sessions, Ms. Williams reported
experiencing two mild panic attacks when driving on highway. She was able to cope with
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them well, using her relaxation skills. In addition, Ms. Williams reported that she still felt
depressed sometimes, although the periods of depression were less frequent and their
intensity was much lower. Ms. Williams also reported that she did not experience alcohol
cravings anymore.
Results of Treatment Outcome and Process Measures
The results of measures taken during the course of treatment are presented in
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Figure 1. Change in OQ-45.2 total score and subscale scores over the course of treatment. Cut-off
scores: total score=63, SD=36, IR=15, SR=12.
Figure 1 indicates that Ms. Williams' total score on the OQ-45.2 decreased from
89 in the beginning of treatment to 49 at termination, falling in the normal range. Ms.
Williams' score on the Symptom Distress subscale decreased from 61 at the beginning of
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treatment to 39 at termination, falling in the dysfunctional range slightly above the cut-
off point. Ms. Williams' score on the Interpersonal relationship subscale decreased from
25 in the beginning of the treatment to 9 at termination, falling in the normal range.
Finally, the Social Relationships subscale score never reached the cut-off point and
remained in the normal range throughout treatment. These results suggest that therapy
was effective in reducing Ms. Williams' problems in interpersonal relationships domain.
Additionally, therapy was effective in reducing distress Ms. Williams experienced from
her symptoms. However, further therapy is needed to further reduce Ms. Williams'
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Figure 2. Number of panic attacks per week (data were not reported by the client for weeks 5 and
11).
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Figure 2 presents the number of panic attacks per week reported by Ms.
Williams during the 17 weeks of treatment. Weeks of treatment rather than sessions are
used in the Figure 2 because Ms. Williams continued collecting data on her panic attacks
during periods when she missed sessions. Figure 2 shows that Ms. Williams experienced
30 panic attacks during 4th week of treatment. The number of panic attacks decreased to
six per week in week 10. In week 12, the number of panic attacks increased to 20 and
then dropped to zero in weeks 13 to 17 with the exception of two panic attacks occurring
in week 15. These results suggest that therapy was effective in reducing the frequency of
panic attacks Ms. Williams experienced. However, further therapy is probably needed to
eliminate panic attacks completely. In addition, further exploration of what factors
contribute to the increased number of panic attacks at various times is warranted. For
example, in week thirteen, it can be seen that the frequency of panic attacks Ms. Williams
experienced increased dramatically to 20 attacks. Further treatment should address more
specifically the causal factors associated with these dramatic changes.
Figure 3 presents the severity ratings (on 0-8 scale, with higher scores indicating
greater levels of distress) reported by Ms. Williams for anxiety, depression, and fear of
panic attacks (average rating per day each week). Figure 3 indicates that fear of panic
attacks evidenced the greatest decrease throughout the course of treatment. Although less
pronounced, anxiety and depression severity ratings also showed a trend toward
continuing decreases in symptoms. These results suggest that treatment Ms. Williams
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Figure 3. Average severity ratings of anxiety, depression, and fear of panic attacks (data were not
reported by the client for weeks 6, 12, and 13).
Ms. Williams' scores on the Combined Alliance Scale are presented in Table 1.
As mentioned previously, Ms. Williams was administered the CAS in the 11th session.
The scores in Table 1 represent Ms. Williams' retrospective estimate of highest and
lowest ratings on each of the five subscales of the CAS, and the ratings for her current
experience in therapy. In addition, percentiles corresponding to each score are presented.
Table 1 indicates that when Ms. Williams evaluated her current experience in therapy, the
scores on all five CAS subscales corresponded to high percentile ratings. These results
suggest that at the time of assessment (11th session) Ms. Williams experienced high
confidence that the therapy is working (Confident Collaboration subscale) and Ms.
Williams and the therapist agreed to a great degree on what should be the focus of
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treatment (Goal and Task Agreement). In addition, Ms. Williams perceived the therapist
as caring about her to a great degree (Bond). Further, Ms. Williams believed that the
therapist was helpful and experienced a little degree of disagreement with the therapist
(Idealized Relationship). Finally, Ms. Williams was highly willing to be open and
forthcoming in the treatment (Dedicated Patient).
Table 1. Scores on the Combined Alliance Scale
Subscale Highest rating Lowest rating Current rating
(percentile) (percentile) (percentile)
Confident Collaboration 35 (90) 25 (30) 35 (90)
Goal and Task Agreement 28 (78) 23 (50) 29 (80)
Bond 33 (90) 28 (67) 35 (90)
Idealized Relationship 35 (90) 34 (80) 34 (80)
Dedicated Patient 35 (90) 30 (80) 35 (90)
Summary
Ms. Williams has had 14 sessions of therapy over 17 weeks of treatment. Ms.
Williams' major problems concerned her panic, depressive, and alcohol use symptoms. In
addition, her recent break-up with her fiance was an issue of great concern. The choice of
the therapeutic approach was guided by research evidence regarding effective treatments,
and Ms. Williams' problems and personal characteristics. The treatment consisted of
cognitive-behavioral and psychodynamic techniques provided within a solid therapeutic
relationship.
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At the beginning of treatment, reducing the frequency and severity of panic
disorder symptoms was the main focus of therapy. Behavioral and psychoeducational
interventions were used to decrease frequency and intensity of Ms. Williams' panic
attacks. Ms. Williams' feelings regarding the loss of the relationship with her fianc6
became the focus of therapy in the middle and late stages of the treatment. In addition,
therapy focused on improvement in depressive symptoms and alcohol use symptoms.
Cognitive and behavioral interventions were used to reduce Ms. Williams' distress
related to the break-up with her fiance and to reduce her symptoms of depression and
alcohol dependence. In addition, cognitive and behavioral interventions were used in the
later stages of treatment to work on Ms. Williams' negative beliefs, to further the
improvement in panic and depressive symptoms, and to prepare Ms. Williams for
termination with this therapist.
Treatment results indicated that Ms. Williams experienced improvement in her
symptoms. Specifically, she evidenced the greatest improvement in the alcohol use and
panic symptoms. In addition, her interpersonal relationships were not the area of concern
anymore. However, further treatment is needed to bring Ms. Williams' symptoms to
normal level. Specifically, she continued to experience mild depressive symptoms and
needed to work on improving her self-esteem.
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Chapter 4
Normative Versus Best Practice
Although Ms. Williams' symptoms responded favorably to the therapy that was
provided to her, there are several ways in which Ms. Williams' treatment could have been
improved.
First, the treatment of Ms. Williams' panic disorder significantly deviated from
the treatment outline by Barlow and Cemy (1988). While the research literature indicates
that treatment of panic disorder is most effective when it includes cognitive restructuring
of catastrophic cognitions characteristic of panic attacks, interoceptive exposure, and
relaxation with breathing retraining; only the relaxation part of the treatment package was
utilized in the current treatment. This was in part due to significant distress Ms. Williams
experienced after her relationship with her fiance ended. Work on the issues related to
this loss needed to be incorporated in therapy sessions, thus shifting the therapy focus.
Still, cognitive restructuring and interoceptive exposure should have been implemented
after the grief over the lost relationship ceased to be acute. Additionally, treatment may
have been improved by more clearly attempting to relate the types of thoughts Ms.
Williams was having about the end of her relationship to the onset of her panic
symptoms/attacks.
The second major area where Ms. Williams' treatment could have been improved
was how her alcohol dependence was treated. Growing consensus in the field of
treatment of dually diagnosed patients (i.e., those diagnosed with substance use disorder
and another psychiatric disorder) suggests that the treatment of both disorders should be
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done concurrently (Brown, 2001). However, the therapist's unfamiliarity with the
current alcohol and dual diagnosis treatment literature and inexperience in alcohol use
treatment lead to insufficient attention being given in therapy to Ms. Williams' alcohol
use.
A related issue was a lack of therapist's knowledge about the importance of group
therapy and self-help groups in the treatment of alcohol dependence. Although evidence
about the effectiveness of self-help groups such as Alcoholics Anonymous in the
treatment of alcohol dependence is inconsistent (Miller et al., 1995), some authors
suggest that group therapy is a treatment of choice for substance dependent clients. For
example, Flores (1997) argues that the majority of substance abusers have a character
pathology that prevents them from developing mutually satisfying and emotionally
intimate relationships. This difficulty in developing healthy relationships is believed to be
one of the major factors leading to substance dependence. Furthermore, it has been
suggested that group treatment might be more helpful than individual treatments because
it would allow the client to work on interpersonal issues with other members in the group.
Clearly, Ms. Williams' pattern of relationships suggests a deficiency in the area of
interpersonal relationships and group therapy addressing this deficiency might have been
especially beneficial for her. Therefore, the therapist could have been more persistent in
recommending that Ms. Williams get involved in Alcoholics Anonymous and group
therapy at the agency. In addition, although Ms. Williams finally started attending AA
meetings, greater involvement in AA earlier in treatment would have helped address the
profound lack of social support she experienced.
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Similarly, the therapist's inexperience in application of cognitive therapy
techniques made it difficult to use cognitive therapy systematically and with maximum
efficacy. For example, while listening to Ms. Williams, the therapist often had difficulty
identifying negative automatic thoughts embedded in her narrative. Once the therapist
learned to tune in to Ms. Williams' automatic thoughts, it was difficult to choose on
which cognition to focus. In addition, once the cognition was chosen the therapist often
experienced difficulty going through the process of disputing and modifying the thought.
Despite these limitations, the therapist did gain some experience in cognitive therapy
while working with Ms. Williams and hopes to expand and improve her skills.
Additionally, Ms. Williams' progress in treatment indicates that the cognitive techniques
that were introduced in treatment did appear to be efficacious in helping the client to
reduce symptomatic distress.
While the shortcomings of the treatment discussed previously were a consequence
of the therapist's inexperience and lack of knowledge, some factors accounting for the
deviation of Ms. Williams' treatment from the best practice lied beyond the therapist's
control. For example, the therapist's clinical supervisor in the agency was unfamiliar with
the empirically validated approaches the therapist attempted to use in treatment. In
addition, although the therapist's supervisor used some cognitive-behavioral techniques
in her work with the clients, she did not use them systematically and did not have a
sufficient expertise in cognitive therapy. Because of that, the therapist has had little
guidance in application of cognitive interventions and had to seek additional consultation
from the study advisor at the Rowan University.
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Another factor that lied beyond the therapist's control was an insufficient
attention that research literature has given to the treatment of dually diagnosed clients in
general and to application of empirically validated treatments to these clients in
particular. This lack of research combined with the therapist's inexperience made it




The purpose of the current project was to track the progress of one client
throughout her involvement with the author who served as her mental health provider. In
doing so, the client's psychosocial assessment was presented, the empirical treatment
literature related to her diagnoses was reviewed, her progress over the course of treatment
was summarized, and a comparison between her current treatment and what might be
considered "best" treatment was presented.
The client was a 41 year-old Caucasian, female. The results of her psychosocial
assessment indicated that she was experiencing a variety of clinical conditions.
Specifically, she was diagnosed with comorbid panic disorder, major depressive disorder,
and alcohol dependence. Her history indicated long-standing anxiety and alcohol abuse
problems and one previous episode of major depressive disorder. Prior to beginning the
current treatment, the client underwent two voluntary hospitalizations for her alcohol
problems, both of which were followed by outpatient counseling that incorporated treatment
of her anxiety and depression. She had been married twice and has a 19-years old daughter.
The client's current struggles with similar symptomology were conceptualized as arising
from multiple stressors including relationship loss, unemployment, financial strain, and
limited social support.
After completing the psychosocial assessment and coming to a conceptual and
diagnostic understanding of the client, a literature review was conducted to explore the
best type of treatment that might be provided to the client. The results of this literature
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review led to a number of conclusions regarding the best type of treatment for a client
with a clinical presentation similar to the current client. These suggestions are briefly
reviewed below.
One conclusion that can be drawn from the literature is that efficacious
psychological and pharmacological treatments exist for each of the client's disorders.
With regard to psychological treatments, results from controlled outcome studies of
treatments for panic disorder have indicated that two manualized treatment packages,
Panic Control Treatment and Cognitive Therapy, are effective at reducing symptoms of
panic disorder. With regard to the treatment of major depressive disorder, results from
controlled outcome studies indicated that two manualized treatment protocols,
Interpersonal Therapy and Cognitive-Behavioral Therapy, are effective at reducing
depressive symptoms. With regard to the treatment of alcohol dependence, various
approaches have been shown to be more effective than standard treatments at reducing
alcohol use and maintaining abstinence. These approaches include brief interventions,
motivational interviewing, and broad-spectrum skills training.
Another conclusion that can be drawn from the literature concerns
pharmacological treatments for panic disorder, major depressive disorder, and alcohol
dependence. SSRIs appear to be the treatment of choice for panic disorder and major
depressive disorder, given their effectiveness and low side effect profile. The literature
also suggested that although benzodiazepines are effective in the treatment of panic
disorder, they should be used cautiously because of their addictive potential. This is
particularly true with clients who have a history of substance dependence. In regard to the
treatment of alcohol dependency, the addition of naltrexone and acamprosate to
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psychosocial treatments has been shown to be effective in the treatment of alcohol
dependence.
Another conclusion that can be drawn from the literature concerns combined
psychological and pharmacological treatments for panic disorder and major depressive
disorder. Some evidence indicates that a TCA or benzodiazepine added to panic disorder
treatment may have short-term, but not long-term advantage. In contrast, an addition of a
SSRI to panic disorder treatment may have both short- and long-term benefit. With
regard to the treatment of MDD, the literature suggested that the addition of a TCA
antidepressant appears to be indicated for clients with severe levels of depression when
they are treated with interpersonal therapy. On the other hand, evidence regarding the
effectiveness of combined CBT and medication was inconclusive.
While fairly definite conclusions can be drawn from the literature on the treatment
of "pure" disorders, conclusions that can be made on the basis of the literature on
psychological and pharmacological treatment of comorbid disorders are tentative. With
regard to psychological treatments, some evidence suggests that comorbid major
depressive disorder does not appear to negatively influence outcome of cognitive-
behavioral treatment for panic disorder and that depressive symptoms do not improve
with the treatment of panic. On the other hand, comorbid panic symptoms appear to
negatively affect the outcome of interpersonal therapy for depression. With regard to
comorbid major depressive disorder and alcohol dependence, cognitive-behavioral
therapy for depression appears to reduce the number and severity of symptoms of both
depression and alcohol use.
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Similarly tentative conclusions can be drawn with regard to pharmacological
treatments ofcomorbid disorders. Some evidence suggests that SSRIs may effectively
reduce both panic and depressive symptoms in comorbid panic disorder and major
depression. Similarly, SSRIs may be effective in the treatment of comorbid depression
and alcohol dependence, reducing both depressive and alcohol use symptoms.
In addition to reviewing the empirical literature, and in keeping with the
recommendations gleaned from the literature, the next goal was to develop a treatment
plan for the client. The client's treatment plan focused on cognitive-behavioral therapy
with a focus on therapeutic relationship and included elements of psychodynamic
therapy. In addition, significant attention was paid to creating and maintaining strong
therapeutic alliance. The therapy focused on reducing symptoms of panic disorder,
exploration and resolution of grief over the ending of a significant relationship, reducing
depressive symptoms and problematic use of alcohol, and exploring the client's negative
beliefs. Assessment of the quality of the therapeutic relationship indicated that strong
therapeutic alliance between the client and the therapist was developed over the course of
treatment.
Overall, the results of the treatment indicated that the treatment was effective.
Specifically, the client experienced a significant reduction in the severity of symptoms
that she was experiencing. This was indicated by both self report and a decrease in
overall symptomatology as measured by the Outcome Questionnaire-45.2. In addition,
the client reported that she was experiencing less panic attacks, that her panic attacks
were not as severe, that she was less fearful of additional panic attacks, and that she was
experiencing lower levels of depressive and anxious symptomology. In addition to
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improved scores on these outcome measures, the client's improvement was evidenced
by behavioral, cognitive, and emotional changes. Specifically, the client became more
engaged in social activities and her engagement in problematic drinking decreased. In
addition, she accepted the fact that her relationship with her fianc6 was over, and she was
more hopeful about her future.
Although the client's symptoms improved, further therapy is needed because the
client continued to experience symptoms of depression. In addition, she expressed her
willingness to work on changing her negative beliefs. A focus on changing these beliefs
may be particularly important in reducing the risk of future relapse in the symptoms the
client has experienced. Since the therapist was leaving the agency, the client was referred
to another therapist to continue her treatment.
In exploring the efficacy of the treatment provided to Ms. Williams, it became
apparent that several factors could have improved the treatment. These factors include
greater use of cognitive and behavioral interventions to reduce symptoms of panic
disorder, greater attention to the client's alcohol use, greater emphasis on AA attendance
and participation in group therapy, and exploring the use of interpersonally based
treatments for this client. In addition, greater research base regarding the treatment of
dually diagnosed clients and better supervision quality at the therapist's agency were the
factors that could have improved Ms. Williams' treatment.
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INFORMED CONSENT
For participating in a study
I agree to participate in a case study which is being conducted by Vera Biryukova under
the supervision of Dr. James Haugh of the Psychology Department, Rowan University.
The purpose of this case study is to help evaluate the effectiveness of the treatment being
provided for by the South Jersey Behavioral Health Resources. The outcomes collected
for this study will be used to help evaluate treatment for disorders.
I understand that this study will not affect my treatment in any way. I will be asked to fill
out some additional tests or measures to better evaluate my treatment. These measures
will not affect my treatment time. The results of the assessments will be shared with me
by my clinician.
I understand that these measures will not leave the agency and will follow the same
confidentiality rules of the SJBHR. I agree that any information obtained from this study
may be used in any way thought best for publication or education, provided that I am in
no way identified and my name is not used.
I understand that there are no physical or psychological risks involved in this study and
that I am free to withdraw my participation at any time without penalty.
I understand that my participation or refusal to participate does not affect any of the
services I receive from the SJBHR.
If I have any questions or problems concerning my participation in this study, I may
contact Vera Biryukova's supervisor Dr. Jim Haugh at 856-256-4500 ext. 3781
or Dr. Janet Cahill at 856-256-4500 ext.3520.
Signature of participant Date
Signature of investigator




permit my therapist to audiotape my therapy sessions.
I understand that audiotaping is for educational purposes only. The information on the
audiotape will be shared with my therapist's supervisor only.
Signature Date
Therapist




Date Time Duration (minutes)
With: Spouse Friend Stranger _ Alone
Stressful situation: yes / no expected: yes / no
Please briefly describe the situation or thoughts that occurred prior to and /or
during the panic attack you are reporting
What caused this panic attack?
Maximum anxiety (circle)
0-----------I----------2----------3-----5- 6- 7-















Fear of going crazy
Fear of losing control
Weekly Record of Anxiety and Depression
Name Week ending
Each evening before you go to bed please rate your average level of anxiety
(taking all things into consideration) throughout the day, the maximum level of
anxiety you experienced that day, your average level of depression throughout the
day, your average feeling of pleasantness throughout the day. Use the scale below.
Next, please list the dosages and amounts of any medication you took. Finally, please
rate, using the scale below, how worried or frightened you were, on average, about
the possibility of having a panic attack throughout the day.
Level of anxiety / depression / pleasant feeling
0 ---------- 1----------2----------3------5- 6- 7- 8
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. .
Relaxation Practice Record
Name Week of to
Relaxation rating: Rate the change in your level of relaxation or tension after practice
session.
-10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 +1 + 2 +3 +4 +5 +6 +7 +8 +9 +10















Day Date Time Anxiety Relaxation Experience during practice (thoughts,
rating feelings, etc.)
Practice I Before After_
Practice2 Before After
Practice I Before After_
Practice2 Before After
Practice I Before After_
Practice2 Before After
Practice 1 Before After _
Practice2 Before After_
Practice 1 Before After _
Practice2 Before After
Practice 1 Before After_
Practice2 Before After
Practice I Before After
Practice2 Before After
Practice I Before After_
Practice2 Before After
